 |
- Condition: Human Immunodeficiency Virus
Intervention: Drug: bictegravir/emtricitabine/tenofovir alafenamide
Sponsors: Midland Research Group, Inc.; Gilead Sciences
Recruiting - Condition: HIV Infections
Interventions: Drug: Oral Cabotegravir (CAB); Drug: Oral Rilpivirine (RPV); Drug: Long-Acting Injectable Cabotegravir (CAB LA); Drug: Long-Acting Injectable Rilpivirine (RPV LA); Drug: Combination Antiretroviral Therapy (cART)
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Not yet recruiting - Condition: Hiv
Intervention: Other: HIV D+/R+
Sponsors: Johns Hopkins University; National Institute of Allergy and Infectious Diseases (NIAID)
Not yet recruiting - Condition: HIV/AIDS
Interventions: Behavioral: Incentivization based on high adherence; Behavioral: Incentivization based on timely clinic visit; Behavioral: Annual adherence prize drawing; Behavioral: Annual viral suppression-based prize drawing; Behavioral: Year 2 booster
Sponsors: RAND; National Institute of Mental Health (NIMH); Mildmay Uganda
Not yet recruiting - Condition: HIV-1 Virologic Response
Interventions: Behavioral: DTP; Behavioral: ICM
Sponsors: Johns Hopkins Bloomberg School of Public Health; University of the Western Cape; TB/HIV Care; University of Toronto; University of California, San Francisco; National Institute for Communicable Diseases, South Africa
Not yet recruiting - Condition: HIV Prevention
Intervention: Drug: bictegravir
Sponsor: Fenway Community Health
Not yet recruiting - Conditions: Substance Use; HIV Risk Behavior
Interventions: Behavioral: Values Affirmation; Behavioral: Risk Feedback
Sponsors: George Mason University; OAR, Fairfax; Slonky, Inc
Not yet recruiting - Condition: HIV/AIDS
Interventions: Dietary Supplement: Beetroot Juice; Dietary Supplement: Placebo
Sponsor: Universidade Federal do Rio de Janeiro
Recruiting - Condition: HIV/AIDS
Intervention: Diagnostic Test: ELIZA , Westron blot
Sponsor: Assiut University
Not yet recruiting - Condition: HIV Infections
Intervention: Biological: HST-NEETs
Sponsor: Children's Research Institute
Recruiting - Condition: HIV-1-infection
Interventions: Drug: Genvoya 150Mg-150Mg-200Mg-10Mg Tablet; Drug: Dolutegravir 50 mg plus one RTI
Sponsors: Ospedale San Raffaele; Gilead Sciences
Recruiting - Conditions: Human Immunodeficiency Virus (HIV); Mitochondrial Diseases
Intervention:
Sponsor: University of Colorado, Denver
Recruiting - Condition: HIV/AIDS
Intervention: Behavioral: Community Health Worker
Sponsors: Massachusetts General Hospital; National Institute of Mental Health (NIMH)
Recruiting - Condition: HIV/AIDS
Intervention: Drug: Truvada
Sponsors: University of Washington; Desmond Tutu HIV Centre; Wits Reproductive Health and HIV Institute; Kenya Medical Research Institute; United States Agency for International Development (USAID); RTI International; Harvard Medical School; University of Pittsburgh
Recruiting - Condition: Anal Neoplasm
Interventions: Biological: VGX-3100; Device: CELLECTRA™ 5PSP
Sponsor: Inovio Pharmaceuticals
Not yet recruiting - Conditions: Human Immunodeficiency Virus; Metabolic Syndrome
Interventions: Behavioral: Intermittent fasting; Behavioral: Standard of Care
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting - Condition: Hiv
Intervention: Behavioral: Peer Navigation
Sponsors: University of California, San Francisco; ANOVA Health Institute; National Institutes of Health (NIH)
Recruiting - Condition: HIV Infections
Intervention: Drug: Single dose of Genvoya® and a single 800 mg dose of Darunavir®
Sponsors: Emory University; Centers for Disease Control and Prevention
Recruiting - Conditions: Human Papilloma Virus; Human Immunodeficiency Virus; Solid Organ Transplant
Intervention: Biological: nine-valent HPV vaccine
Sponsor: Universitaire Ziekenhuizen Leuven
Not yet recruiting - Conditions: HIV/AIDS; Aging; Mild Cognitive Impairment; Group, Peer
Interventions: Behavioral: CRGT; Behavioral: HIV group therapy
Sponsors: University Health Network, Toronto; CIHR Canadian HIV Trials Network; St. Michael's Hospital, Toronto; AIDS Committee of Toronto (ACT); Factor-Inwentash Faculty of Social Work, University of Toronto
Recruiting - Conditions: HIV/AIDS; Tuberculosis
Interventions: Behavioral: Incentives for negative EtG test; Behavioral: Incentives for positive IsoScreen test
Sponsors: University of California, San Francisco; Infectious Diseases Research Collaboration, Uganda; Mbarara University of Science and Technology
Not yet recruiting - Conditions: Tuberculosis, Pulmonary; AIDS
Interventions: Drug: Rifampicin; Drug: Rifabutin
Sponsors: Shanghai Public Health Clinical Center; The Guangxi Zhuang Autonomous Region Longtan hospital; The Fourth People’s Hospital of Nanning; Shenzhen Third People's Hospital; Yunnan Provincial Infectious Disease Hospital; Zhejiang University; Chongqing Infectious Disease Medical Center
Not yet recruiting - MySTYLE: Online Family-based HIV Prevention for Non-heterosexual Black Adolescent Males in the SouthConditions: Hiv; Adolescent Behavior; Family Relations; Sexual Orientation
Interventions: Behavioral: MySTYLE; Behavioral: MyHealth
Sponsors: Rhode Island Hospital; University of Mississippi Medical Center
Not yet recruiting - Conditions: ART Adherence; PMTCT; Linkage to Care; HIV; PrEP
Interventions: Behavioral: HIV self-test kit; Behavioral: Standard of Care
Sponsors: University of Washington; National Institute of Mental Health (NIMH); Harvard University; University of North Carolina, Chapel Hill
Not yet recruiting - Condition: HIV Infections
Intervention: Behavioral: ChiCAS
Sponsor: Centers for Disease Control and Prevention
Not yet recruiting - Condition: HIV-1-infection
Interventions: Drug: GS-9131; Drug: Placebo; Drug: BIC; Drug: DRV; Drug: RTV; Drug: ART regimen
Sponsor: Gilead Sciences
Not yet recruiting - Condition: Pneumococcal Infections
Interventions: Biological: V114; Biological: Prevnar 13™; Biological: PNEUMOVAX™23
Sponsor: Merck Sharp & Dohme Corp.
Not yet recruiting - Condition: HIV in MSM
Intervention: Behavioral: ESTEEM conneCT
Sponsors: Yale University; National Institute of Mental Health (NIMH)
Not yet recruiting - Condition: HIV-1-infection
Intervention: Drug: Anti-Retroviral Agents
Sponsor: Shanghai Public Health Clinical Center
Recruiting - Condition: Infection, Human Immunodeficiency Virus
Intervention: Drug: cabotegravir, CAB
Sponsor: ViiV Healthcare
Available - Conditions: HIV; Metabolic Syndrome; Osteopenia; Osteoporosis; Vitamin D Deficiency; Renal Impairment; Liver Fibroses
Intervention:
Sponsor: Chinese University of Hong Kong
Not yet recruiting - Conditions: Substance Use; Sexual Risk
Interventions: Behavioral: YMHP Intervention; Behavioral: Enhanced Treatment as Usual
Sponsors: Hunter College of City University of New York; National Institute on Drug Abuse (NIDA)
Recruiting - Condition: HIV/AIDS
Intervention: Behavioral: NIDA Standard for HIV Prevention
Sponsors: University of Kentucky; National Institute on Drug Abuse (NIDA)
Not yet recruiting - Condition: Hiv
Intervention: Behavioral: Enhanced Couple HIV Testing and Counseling
Sponsors: University of North Carolina, Chapel Hill; National Institute of Mental Health (NIMH)
Recruiting - Condition: Human Immunodeficiency Virus
Intervention: Combination Product: 123I radiolabeled 3BNC117
Sponsor: University of Lausanne Hospitals
Recruiting - Conditions: Sexual Dysfunction; HIV; Hepatitis C
Intervention:
Sponsors: University Paris 7 - Denis Diderot; University of Sydney; Center of treatment HIV/Aids-São Paulo; Université de Montréal
Recruiting - Conditions: HIV Infections; Sexually Transmitted Diseases
Interventions: Behavioral: HEART; Behavioral: Growing Minds
Sponsor: North Carolina State University
Recruiting - Conditions: HIV; Seroconversion, HIV
Intervention: Drug: Early combination anti-retroviral treatment
Sponsors: University Hospital, Ghent; ViiV Healthcare
Recruiting - Condition: Hiv
Intervention: Behavioral: Incentive for linkage to care
Sponsors: University of California, Berkeley; National Institute of Mental Health (NIMH); Ministry of Health and Social Welfare, Tanzania
Recruiting - Condition: HIV Infections
Interventions: Drug: Continue with triple therapy; Drug: Switch to DTG + 3TC; Drug: Switch to DRV/cobicistat + 3TC
Sponsors: Hospitales Universitarios Virgen del Rocío; Fundación Pública Andaluza para la gestión de la Investigación en Sevilla
Recruiting - Condition: HIV/AIDS
Intervention: Drug: HIV prevention package including PrEP
Sponsors: French National Institute for Health and Medical Research-French National Agency for Research on AIDS and Viral Hepatitis (Inserm-ANRS); Expertise France; TransVIHMI (IRD, Inserm, Université de Montpellier); SESSTIM (IRD, Inserm, Université Aix-Marseille); Coalition Internationale Sida, Pantin, France; Institut de Médecine Tropicale, Anvers, Belgique; ARCAD-SIDA, Bamako, Mali; Association African Solidarité, Ouagadougou, Burkina Faso; Centre de Recherche Internationale pour la Santé, Université de Ouagadougou; Espace Confiance, Abidjan, Côte d'Ivoire; Espoir Vie Togo, Lomé, Togo; Laboratoire BIOLIM, Université de Lomé
Recruiting - Condition: Hiv
Intervention: Other: Non Interventional Study
Sponsor: Nantes University Hospital
Not yet recruiting - Conditions: HIV/AIDS; Hepatitis C
Intervention: Behavioral: Assisted Partner Services
Sponsors: University of Washington; National Institute on Drug Abuse (NIDA); Kenyatta National Hospital; Kenya Ministry of Health; University of KwaZulu
Recruiting - Condition: Infection, Human Immunodeficiency Virus
Interventions: Drug: DTG + 3TC; Drug: TAF based regimen (TBR)
Sponsors: ViiV Healthcare; GlaxoSmithKline
Recruiting - Condition: HIV Infections
Interventions: Behavioral: Alere q HIV-1/2 Detect for point of care infant testing; Behavioral: GeneXpert HIV-1 Qual for point of care infant testing; Behavioral: HIV DNA PCR testing (Standard of Care)
Sponsors: University of Kansas Medical Center; Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Recruiting - Condition: HIV/AIDS
Interventions: Behavioral: HIV Testing Message Intervention; Behavioral: Control
Sponsors: Virginia Commonwealth University; National Institute on Minority Health and Health Disparities (NIMHD)
Not yet recruiting - Condition: HIV-related Mild Neurocognitive Disorder
Interventions: Procedure: Transcranial Direct Current Stimulation (tDCS); Behavioral: Computer-based Cognitive Training; Behavioral: Watching Educational Videos
Sponsor: Nova Southeastern University
Recruiting - Condition: HIV/AIDS
Interventions: Other: Three monthly ART supply at CAGs; Other: Six monthly ART supply at outreaches
Sponsors: Equip, Lesotho; Ministry of Health, Lesotho; United States Agency for International Development (USAID); Elizabeth Glaser Pediatric AIDS Foundation; Lesotho Network of AIDS Services Organizations; National Drugs Service Organisation of Lesotho; Chemonics
Recruiting - Conditions: HIV Infections; Alcohol Abuse
Interventions: Behavioral: Brief Electronic Intervention; Behavioral: Attention-Matched Control
Sponsor: Brown University
Not yet recruiting - Condition: HIV
Intervention: Behavioral: Game Changers
Sponsors: RAND; Infectious Diseases Institute, Uganda
Not yet recruiting - Conditions: HIV/AIDS; Diabetes Mellitus, Type 2; Hypertension
Intervention: Other: Medication optimization intervention
Sponsors: University of North Texas Health Science Center; University of California, San Francisco; University of Minnesota - Clinical and Translational Science Institute
Not yet recruiting - Condition: HIV Infections
Interventions: Drug: Treatment A; Drug: Treatment B; Drug: Treatment C; Drug: Treatment D; Drug: Treatment E; Drug: Treatment F
Sponsors: ViiV Healthcare; GlaxoSmithKline; Pharmaceutical Product Development (PPD), Inc
Not yet recruiting - Condition: HIV/AIDS
Intervention: Device: OraQuick HIV Self-Test
Sponsors: Makerere University; University of Washington; Massachusetts General Hospital; Harvard Medical School
Not yet recruiting - Condition: HIV
Intervention: Behavioral: Siempre Seguiré
Sponsors: RAND; Bienestar Human Services, Inc.
Not yet recruiting - Conditions: Respiratory Tract Infections; HIV Infections
Intervention: Combination Product: 3HP plus DTG +2NRTIs
Sponsors: Prof Gavin John Churchyard; Johns Hopkins University; University of California
Recruiting - Condition: HIV Infections
Interventions: Drug: Oral CAB; Drug: CAB LA
Sponsors: ViiV Healthcare; ViiV Healthcare; ADARC (US)
Recruiting - Condition: Human Immunodeficiency Virus
Interventions: Drug: Vitamin D3, 10000 Intl Units Oral Capsule; Drug: Placebo oral capsule
Sponsors: University of Melbourne; Melbourne Health; The Alfred; Melbourne Sexual Health Centre; University of Illinois at Chicago
Recruiting - Condition: HIV
Intervention: Other: Systems Analysis and Improvement Approach (SAIA)
Sponsors: University of Washington; Ministry of Health, Mozambique; Health Alliance International; Fred Hutchinson Cancer Research Center; National Institute of Mental Health (NIMH)
Not yet recruiting - Conditions: HIV; Pregnancy Malaria; Sexually Transmitted Infection
Interventions: Drug: Azithromycin/TMPS; Drug: Placebo/TMPS
Sponsor: University of Alabama at Birmingham
Recruiting - Condition: HIV-1-infection
Interventions: Procedure: Leukapheresis; Procedure: Lymph node biopsy
Sponsors: University of Melbourne; amfAR, The Foundation for AIDS Research; University of California, San Francisco; Monash University; Université de Montréal; The Avenue Hospital; Oregon Health and Science University; Johns Hopkins University
Recruiting - Condition: HIV Infections
Intervention:
Sponsor: Chinese University of Hong Kong
Not yet recruiting - Condition: HIV-1-infection
Intervention:
Sponsors: International Maternal Pediatric Adolescent AIDS Clinical Trials Group; National Institute of Allergy and Infectious Diseases (NIAID); Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD); National Institute of Mental Health (NIMH)
Not yet recruiting - Conditions: Hiv; HIV/AIDS; Disclosure
Interventions: Behavioral: Tough Talks Online; Behavioral: Tough Talks Clinic; Behavioral: Standard of Care
Sponsors: University of North Carolina, Chapel Hill; Virtually Better, Inc.; National Institute of Mental Health (NIMH)
Not yet recruiting - Conditions: Chronic Hepatitis B in HIV Patient; Kidney Injury; Bone Diseases
Intervention: Drug: Elvitegravir/Cobicistat/Emtricitabine
Sponsors: National Taiwan University Hospital; National Taiwan University Hospital Hsin-Chu Branch; National Taiwan University Hospital, Yun-Lin Branch; Far Eastern Memorial Hospital; Taoyuan General Hospital; Mackay Memorial Hospital; Chung Shan Medical University; Taichung Veterans General Hospital; National Cheng-Kung University Hospital; Changhua Christian Hospital; Chi Mei Medical Hospital; Kaohsiung Veterans General Hospital.; Kaohsiung Medical University Chung-Ho Memorial Hospital; Chang Gung Memorial Hospital; E-DA Hospital; Lotung Poh-Ai Hospital
Not yet recruiting - Condition: HIV Infections
Interventions: Biological: env (A,B,C,A/E)/gag (C) DNA Vaccine; Biological: gp120 (A,B,C,A/E) Protein Vaccine; Biological: Placebo; Biological: GLA-SE adjuvant
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting - Condition: HIV Infections
Intervention: Drug: PC-1005 gel
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Not yet recruiting - Condition: HIV Infections
Intervention:
Sponsor: Johns Hopkins University
Recruiting - Conditions: Hiv; Sexually Transmitted Diseases; Mental Health Wellness 1
Intervention:
Sponsor: Oslo University Hospital
Recruiting - Condition: HIV
Intervention: Behavioral: FUERTES
Sponsors: Instituto Nacional de Salud Publica, Mexico; Hospital Civil Juan I. Menchaca; Hospital General de Occidente
Recruiting - Condition: Foreskin HIV Susceptibility
Interventions: Drug: Oral Tinidazole; Drug: Topical metronidazole; Drug: Topical Clindamycin; Drug: Topical Hydrogen Peroxide
Sponsors: University of Toronto; UVRI-IAVI HIV Vaccine Program; Entebbe General Hospital
Recruiting - Condition: HIV/AIDS
Interventions: Drug: Elvitegravir, Cobicistat, TAF, FTC; Drug: Efavirenz, TDF, and 3TC
Sponsors: Haitian Group for the Study of Kaposi's Sarcoma and Opportunistic; Gilead Sciences; Brigham and Women's Hospital; Weill Medical College of Cornell University; Analysis Group, Inc.
Not yet recruiting - Condition: HIV Infections
Intervention:
Sponsors: University College, London; King's College London
Not yet recruiting - Condition: Human Immunodeficiency Virus
Interventions: Biological: Ad4-EnvCN54; Biological: MVA-CN54; Biological: CN54gp140/MPLA
Sponsor: Imperial College London
Recruiting - Condition: HIV-infection/AIDS
Interventions: Drug: Triptolide Wilfordii; Drug: Placebo Oral Tablet
Sponsor: Peking Union Medical College Hospital
Not yet recruiting - Conditions: HIV; ART; Zinc Deficiency; Selenium Deficiency; Metabolic Complication; Inflammation
Intervention: Dietary Supplement: Zinc gluconate and/or Selenium yeast
Sponsor: Instituto Nacional de Enfermedades Respiratorias
Recruiting - Conditions: HIV/AIDS; Substance Use; Bisexuality
Intervention: Behavioral: HIV and substance use prevention
Sponsor: Northwestern University
Not yet recruiting - Condition: HIV Infections
Interventions: Behavioral: Social Media Messages Intervention Group; Behavioral: Website Only Group
Sponsors: Brown University; Centers for Disease Control and Prevention
Recruiting - Condition: HIV-1-infection
Intervention: Drug: B/F/TAF
Sponsor: Gilead Sciences
Recruiting - Condition: HIV Infections
Intervention: Other: FAM-CARE
Sponsors: Elizabeth Glaser Pediatric AIDS Foundation; United States Agency for International Development (USAID); Ministry of Health, Swaziland
Recruiting - Condition: Infection, Human Immunodeficiency Virus
Interventions: Other: Functional Assessment of HIV Infection; Other: Patient Satisfaction Questionnaire; Other: Symptom Distress Module; Other: Patient Health Questionnaire; Other: Internalized Stigma of AIDS Tool; Other: Medication adherence visual analogue scale
Sponsors: ViiV Healthcare; Evidera; mProve
Recruiting - Conditions: HIV-1-infection; Gut Inflammation
Intervention: Drug: Pentasa vs Align
Sponsors: AIDS Healthcare Foundation; HIV Immunotherapeutics Institute
Recruiting - Condition: HIV Infections
Interventions: Behavioral: Daily ART-adherence SMS reminder; Behavioral: Standard Adherence Counselling/Patient experience group chat
Sponsor: Dr. Olumide ABIODUN
Not yet recruiting - Conditions: Malaria; Malaria,Falciparum
Interventions: Biological: PfSPZ Vaccine; Other: Normal Saline Placebo; Biological: PfSPZ Challenge
Sponsors: Sanaria Inc.; Ifakara Health Institute; Swiss Tropical & Public Health Institute; Medical Care Development, Inc.
Recruiting - Condition: HIV Infections
Intervention: Drug: Dapivirine gel
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Not yet recruiting - Condition: HIV-2 Infection
Interventions: Diagnostic Test: HIV-2 Genotypic Drug Resistance Testing using DBS; Drug: 2nd line ART ( Zidovudine 300mg BID + Lamivudine 150mg BID or Tenofovir DF 300mg QD + Lamividine 300mg QD or Emtricitabine 200mg QD + Lopinavir/Ritonavir 400/100mg BID); Drug: 2nd line ART (Tenofovir DF 300mg QD + Lamividine 300mg QD or Emtricitabine 200mg QD + Lopinavir/Ritonavir 400/100mg BID + Raltegravir 400mg BID ); Drug: 2nd line ART (Tenofovir DF 300mg QD + Lamividine 300mg QD or Tenofovir DF 300mg QD + Emtricitabine 200mg QD + Darunavir 600mg BID-Ritonavir 100mg BID +Raltegravir 400mg BID)
Sponsors: University of Washington; Clinique des Maladies Infectieuses, CHNU de Fann, Dakar, Senegal; Centre de Sante de Ziguinchor, Casamance, Senegal; Janssen Pharmaceutica; Merck Sharp & Dohme Corp.; National Institute of Allergy and Infectious Diseases (NIAID)
Not yet recruiting - Infectious Diseases and Movement Program: Study of the Effects of Physical Activity on HIV InfectionCondition: HIV-1-infection
Intervention: Behavioral: physical activity
Sponsor: University of Roma La Sapienza
Recruiting - Conditions: HIV/AIDS; Insomnia
Intervention: Behavioral: SHUTi
Sponsor: Indiana University
Not yet recruiting - Condition: HIV Infection Primary
Intervention: Device: TEAMH App
Sponsors: Northwell Health; Gilead Sciences
Recruiting - Condition: HIV Infections
Interventions: Drug: Emtricitabine/Tenofovir Disoproxil Fumarate (FTC/TDF); Behavioral: Behavioral HIV risk reduction package
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Not yet recruiting - Condition: HIV Infections
Intervention: Biological: VRC07-523LS
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting - Conditions: HPV - Anogenital Human Papilloma Virus Infection; Hiv
Intervention: Biological: Vaccine
Sponsor: Centre Hospitalier Universitaire Saint Pierre
Not yet recruiting - Conditions: Hepatitis C; HIV; Type2 Diabetes
Intervention:
Sponsor: Icahn School of Medicine at Mount Sinai
Recruiting - Conditions: HIV/AIDS; Medication Adherence; Substance Use
Intervention: Behavioral: ATHENA
Sponsors: University of Illinois at Chicago; Indonesia University
Recruiting - Condition: HIV Infections
Interventions: Biological: gp145 C.6980 Vaccine; Biological: Placebo; Biological: Aluminum Hydroxide Adjuvant
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting - Condition: HIV Associated Cognitive Motor Complex
Interventions: Drug: Galantamine; Drug: Placebo
Sponsors: University of Pennsylvania; National Institute on Drug Abuse (NIDA)
Recruiting - Condition: HIV Infections
Interventions: Drug: Tamoxifen; Drug: Vorinostat; Drug: Antiretroviral drugs
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Not yet recruiting - Conditions: Adherence, Medication; Risk Reduction; Drug Use; Sex, Anal; HIV/AIDS
Interventions: Behavioral: PARTNER; Behavioral: Education Intervention
Sponsors: Hunter College of City University of New York; National Institute on Drug Abuse (NIDA)
Recruiting - Conditions: HIV Infections; Neonatal Infection; LTBI - Latent Tuberculosis Infection; Immune Tolerance
Intervention: Other: RNAseq
Sponsors: George Washington University; Universitatea de Stat de Medicina si Farmacie Nicolae Testemiţanu; Children's Research Institute; DC-Center for Aids Research (DC-CFAR); SeqLL, Inc.
Recruiting - Condition: HIV Infections
Intervention:
Sponsor: Centre de Recherches et d'Etude sur la Pathologie Tropicale et le Sida
Not yet recruiting - Condition: Infection, Human Immunodeficiency Virus
Intervention: Procedure: Blood sampling
Sponsors: GlaxoSmithKline; University Ghent
Recruiting - Condition: Human Immunodeficiency Virus
Interventions: Other: Placebo; Drug: Pembrolizumab
Sponsor: National Institutes of Health Clinical Center (CC)
Recruiting - Conditions: Risk Behavior; Drug Use; Sex, Anal
Interventions: Behavioral: Couples Health Project (CHP); Behavioral: Education
Sponsors: Hunter College of City University of New York; National Institute on Drug Abuse (NIDA)
Not yet recruiting - Conditions: HIV Infections; Antiretroviral Therapy; HIV Seropositivity
Intervention: Behavioral: Mobile phone reminder
Sponsors: Tokyo University; Asian Development Bank Japan Scholarship Program; Open Society Institute
Recruiting - Conditions: Pharmacogenetics; HIV; Drug Monitoring
Interventions: Genetic: Pharmacogenomic index; Diagnostic Test: Therapeutic drug monitoring
Sponsor: Hospital Italiano de Buenos Aires
Recruiting - Condition: HIV-1 Infected Adults With Controlled Viremia
Intervention: Genetic: VRC-HIVAAV070-00-GT (AAV8-VRC07)
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting - Condition: HIV/AIDS
Interventions: Behavioral: Immediate Fast-Track Care; Behavioral: Deferred Fast-Track Care
Sponsors: Brigham and Women's Hospital; Haitian Group for the Study of Kaposi's Sarcoma and Opportunistic; Weill Medical College of Cornell University; Duke University; Florida International University; Analysis Group, Inc.
Not yet recruiting - Condition: HIV Infections
Intervention: Dietary Supplement: Artemisia Annua, Moringa oleifera
Sponsors: Mbarara University of Science and Technology; ANAMED
Not yet recruiting - Conditions: HIV/AIDS and Infections; Drug Abuse; Adolescent Behavior; Drug Usage
Interventions: Behavioral: S4E; Behavioral: Usual Care
Sponsor: University of Michigan
Not yet recruiting - Conditions: HIV Seropositivity; Metabolic Syndrome; Fatty Liver
Intervention: Drug: Raltegravir
Sponsors: Helsinki University Central Hospital; Merck Sharp & Dohme Corp.
Not yet recruiting - Conditions: Hepatitis C Virus Infection, Response to Therapy of; Human Immunodeficiency Virus
Intervention: Drug: sofosbuvir and daclatasvir
Sponsors: Tehran University of Medical Sciences; RojanPharma Pharmaceutical Company
Recruiting - Conditions: HIV/AIDS; Contraception
Interventions: Drug: Tenofovir Disoproxil Fumarate; Drug: Depo-Provera
Sponsors: University of Minnesota - Clinical and Translational Science Institute; MU-JHU CARE
Recruiting - Conditions: Human Immunodeficiency Virus; Hepatitis C; Alcohol Abuse
Interventions: Behavioral: Computer-based alcohol reduction intervention; Behavioral: Standard-of-care
Sponsors: Emory University; National Institute on Alcohol Abuse and Alcoholism (NIAAA)
Recruiting - Condition: HIV/AIDS
Interventions: Other: Intensified monitoring; Other: Standard of care monitoring
Sponsors: UMC Utrecht; ZonMw: The Netherlands Organisation for Health Research and Development; Ndlovu Care Group; Wits Reproductive Health and HIV Institute
Recruiting - Condition: HIV-1 Infection
Intervention: Drug: MK-4250
Sponsor: Merck Sharp & Dohme Corp.
Recruiting - Conditions: HIV-1-infection; Solid Organ Transplant
Interventions: Drug: Lamivudine 300 MG; Drug: Abacavir 600 MG; Drug: Dolutegravir 50 mg; Drug: Tenofovir Disoproxil 245Mg Tablet; Drug: Emtricitabine 200 MG
Sponsor: Fundacion Clinic per a la Recerca Biomédica
Not yet recruiting - Condition: HIV/AIDS
Intervention: Behavioral: Exercise
Sponsors: Instituto Nacional de Cardiologia de Laranjeiras; Rio de Janeiro State University
Recruiting - Conditions: HPV - Anogenital Human Papilloma Virus Infection; HSIL, High Grade Squamous Intraepithelial Lesions; Anal Cancer; Hiv
Intervention:
Sponsors: Hospital Universitari de Bellvitge; Institut d'Investigació Biomèdica de Bellvitge
Recruiting - Condition: HIV Infected Patients With Cancer Treated by ICPi
Intervention: Biological: Blood sample
Sponsors: French National Institute for Health and Medical Research-French National Agency for Research on AIDS and Viral Hepatitis (Inserm-ANRS); Pitié-Salpêtrière Hospital; Bicetre Hospital
Recruiting - Condition: HIV-1-infection
Interventions: Other: Survey; Other: Focus Group; Other: Usability study
Sponsors: University of Florida; National Institute on Alcohol Abuse and Alcoholism (NIAAA)
Recruiting - Condition: HIV
Intervention: Biological: NK cells and IL-2
Sponsor: University of Minnesota - Clinical and Translational Science Institute
Recruiting - Conditions: Comorbidities; HIV/AIDS
Intervention: Other: Collection of data
Sponsors: Asociacion para el Estudio de las Enfermedades Infecciosas; Merck Sharp & Dohme Corp.
Recruiting - Condition: HIV Infections
Interventions: Drug: B/FTC/TAF; Drug: Current ART
Sponsors: The University of Texas Health Science Center, Houston; Gilead Sciences
Not yet recruiting - Condition: HIV-1-infection
Interventions: Other: Medicines Optimisation Review toolkit; Other: Standard of Care
Sponsors: Brighton and Sussex University Hospitals NHS Trust; Merck Sharp & Dohme Corp.
Not yet recruiting - Condition: HIV/AIDS
Intervention: Behavioral: Rise - Treatment Education
Sponsor: RAND
Recruiting - Condition: HIV/AIDS
Intervention:
Sponsors: Michael Hoelscher; National Institute for Medical Research - Mbeya Medical Research Centre (NIMR-MMRC); University Clinic of Cologne, Department of Internal Medicine, Center for Molecular Medicine Cologne (CMMC); Max von Pettenkofer-Institute of the University of Munich (LMU), Department of Virology
Recruiting - Condition: HIV Infections
Interventions: Drug: Doravirine (DOR); Drug: Doravirine/Lamivudine/Tenofovir Disoproxil Fumarate (DOR/3TC/TDF); Drug: Antiretroviral (ARV) medications
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting - Condition: HIV/AIDS
Intervention: Behavioral: Intervention Group
Sponsors: Michael Ohl; Gilead Sciences
Recruiting - Conditions: Contraceptive Usage; HIV Infections; Drug Interaction
Interventions: Drug: dolutegravir; Device: ENG implant; Drug: Efavirenz
Sponsor: Columbia University
Recruiting - Conditions: Hiv; Opioid Dependence; Smoking Cessation
Interventions: Drug: Bupropion; Behavioral: Positively smoke free; Other: Brief advice to quit smoking
Sponsor: University of Maryland
Not yet recruiting - Conditions: HIV Seropositivity; HIV Infections; HIV-1-infection
Interventions: Drug: Raltegravir; Drug: Lamivudine
Sponsors: David Garcia Cinca; Fundacion Clinic per a la Recerca Biomédica
Not yet recruiting - Condition: HIV-1-infection
Intervention: Biological: Oral fecal microbiota transplantation
Sponsor: The University of Texas Health Science Center, Houston
Not yet recruiting - Condition: HIV Prevention
Intervention: Drug: Tenofovir disoproxil fumarate (TDF)/emtricitabine (FTC)
Sponsors: Kirby Institute; Government of Western Australia, Department of Health; Western Australia AIDS Council
Not yet recruiting - Conditions: HIV/AIDS; HIV Infections; Social Media
Interventions: Behavioral: HIV risk assessment and tailored suggestions; Behavioral: HIV risk behavior assessment; Behavioral: placebo control
Sponsor: National Center for AIDS/STD Control and Prevention, China CDC
Recruiting - Condition: HIV/AIDS
Intervention: Behavioral: Join-In-Circuit on AIDS, Love & Sexuality
Sponsors: Columbia University; German Development Corporation; American Institutes for Research
Recruiting - Conditions: Hiv; Adherence, Patient; Care Continuum
Intervention: Behavioral: Transitional Community Adherence Club
Sponsors: Johns Hopkins University; Aurum Institute
Not yet recruiting - Conditions: HIV/AIDS; Antiretroviral Therapy
Intervention: Procedure: SLATE II
Sponsors: Boston University; University of Witwatersrand, South Africa; Bill and Melinda Gates Foundation
Recruiting - Condition: HIV Infection
Intervention: Drug: Recombinant Interleukin-2
Sponsor: Case Western Reserve University
Not yet recruiting - Condition: HIV Prevention
Intervention: Behavioral: Employment Intervention
Sponsors: University of North Carolina, Chapel Hill; Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD); National Institute on Drug Abuse (NIDA); National Institute of Mental Health (NIMH)
Recruiting - Condition: HIV/AIDS
Interventions: Behavioral: Youth Development Accounts (YDA); Behavioral: YDA + Multiple Family Groups (MFG)
Sponsors: Washington University School of Medicine; National Institute of Mental Health (NIMH)
Not yet recruiting - Conditions: HIV Infections; HIV-1-infection; HIV Seropositivity
Interventions: Drug: Raltegravir; Drug: Lamivudine
Sponsors: David Garcia Cinca; Fundacion Clinic per a la Recerca Biomédica
Not yet recruiting - Condition: HIV/AIDS
Intervention: Behavioral: PrEP Education and option to accept a PrEP prescription
Sponsor: Drexel University
Not yet recruiting - Condition: Infection, Human Immunodeficiency Virus
Interventions: Behavioral: Risk reduction counseling; Other: Social harm interview; Other: Computer-Assisted Self Interviewing technique
Sponsor: ViiV Healthcare
Recruiting - Condition: Human Immunodeficiency Virus
Interventions: Biological: Ad26.Mos4.HIV; Biological: MVA-Mosaic; Biological: Clade C gp140 + Mosaic gp140; Drug: Placebo
Sponsors: Janssen Vaccines & Prevention B.V.; Beth Israel Deaconess Medical Center; Ragon Institute of MGH, MIT and Harvard; US Military HIV Research Program
Not yet recruiting - Condition: Mother to Child Transmission of HIV
Intervention:
Sponsor: French National Institute for Health and Medical Research-French National Agency for Research on AIDS and Viral Hepatitis (Inserm-ANRS)
Recruiting - Conditions: Cervical Cancer; HIV/AIDS
Intervention: Diagnostic Test: 2-stage screen
Sponsors: Beth Israel Deaconess Medical Center; National Institute of Allergy and Infectious Diseases (NIAID)
Not yet recruiting - Condition: HIV Infections
Intervention: Other: Blood sample
Sponsor: French National Institute for Health and Medical Research-French National Agency for Research on AIDS and Viral Hepatitis (Inserm-ANRS)
Not yet recruiting - Condition: HIV Infections
Interventions: Drug: Cabotegravir Tablets; Drug: Rilpivirine Tablets; Drug: Cabotegravir Injectable Suspension; Drug: Rilpivirine Injectable Suspension
Sponsors: ViiV Healthcare; Janssen Research and Development
Recruiting - Conditions: HIV Infections; Antiretroviral Agents
Intervention:
Sponsors: University Hospital, Bordeaux; Agence Nationale de Recherches contre le SIDA et les hépatites virales (ANRS); Institut National de la Santé Et de la Recherche Médicale, France; French Ministry of Health through the COREVIH Aquitaine
Recruiting - Conditions: Tuberculosis; HIV/AIDS
Interventions: Behavioral: SPIRIT Intervention; Combination Product: Single Pill Combination; Other: Reduced Refill Frequency Intervention
Sponsors: University of California, San Francisco; Makerere University; National Institute of Allergy and Infectious Diseases (NIAID); Cipla Ltd.
Recruiting - Conditions: Non Small Cell Lung Cancer Metastatic; Non Small Cell Lung Cancer Stage IIIB; HIV/AIDS
Intervention: Drug: Nivolumab Injection
Sponsors: Intergroupe Francophone de Cancerologie Thoracique; French National Institute for Health and Medical Research-French National Agency for Research on AIDS and Viral Hepatitis (Inserm-ANRS)
Recruiting - Conditions: Contraception; Hiv
Intervention:
Sponsors: University of Pittsburgh; National Institutes of Health (NIH)
Recruiting - Condition: Human Immunodeficiency Virus
Intervention: Other: Questionnaire
Sponsor: Imperial College London
Recruiting - Conditions: HIV; Herpesvirus 8, Human; Retroviridae
Intervention:
Sponsor: National Cancer Institute (NCI)
Recruiting - Condition: HIV Positive
Interventions: Behavioral: Positive Health Check; Behavioral: Standard of Care
Sponsors: RTI International; Centers for Disease Control and Prevention
Recruiting - Condition: HIV/AIDS
Intervention: Combination Product: Storytelling Narrative Intervention
Sponsors: University of Massachusetts, Boston; Dana-Farber Cancer Institute
Recruiting - Condition: HIV Infections
Interventions: Behavioral: TERA Intervention; Behavioral: Standard of Care
Sponsors: University of North Carolina, Chapel Hill; Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD); National Institute of Mental Health (NIMH); National Institute on Drug Abuse (NIDA); National Institute on Minority Health and Health Disparities (NIMHD)
Recruiting - Conditions: Human Immunodeficiency Virus (HIV); Hepatitis c
Intervention: Behavioral: semi-directed interviews
Sponsor: University Hospital, Bordeaux
Recruiting - Condition: Smoking
Intervention: Other: Tobacco smoking and nicotine patch
Sponsor: University of Maryland
Not yet recruiting - Condition: HIV Infections
Interventions: Biological: ALVAC-HIV (vCP2438); Biological: Bivalent Subtype C gp120/MF59; Biological: Bivalent Subtype C gp120 admixed with Al(OH)3 Suspension; Biological: Bivalent Subtype C gp120
Sponsors: National Institute of Allergy and Infectious Diseases (NIAID); HIV Vaccine Trials Network; Sanofi Pasteur, a Sanofi Company; GlaxoSmithKline
Recruiting - Condition: HIV Infections
Intervention: Drug: PrEP
Sponsor: Yale University
Recruiting - Condition: Hiv
Interventions: Behavioral: PrEP Mobile Messaging Intervention; Behavioral: Enhanced Standard of Care
Sponsors: Rhode Island Hospital; University of Mississippi Medical Center
Not yet recruiting - Condition: HIV
Intervention: Diagnostic Test: point-of-care viral load test
Sponsors: Weill Medical College of Cornell University; Haitian Group for the Study of Kaposi's Sarcoma and Opportunistic
Not yet recruiting - Conditions: Tuberculosis; HIV/AIDS; Alcohol Abuse
Interventions: Drug: Isoniazid 300 Mg ORAL TABLET; Drug: Pyridoxine 25 Mg Oral Tablet
Sponsors: University of California, San Francisco; Boston University; Boston Medical Center; Mbarara University of Science and Technology
Recruiting - Condition: HIV Infections
Intervention:
Sponsor: Azienda Ospedaliera Spedali Civili di Brescia
Recruiting - Condition: HIV
Intervention: Behavioral: FANMI - Cohort Care
Sponsors: Weill Medical College of Cornell University; Haitian Group for the Study of Kaposi's Sarcoma and Opportunistic
Not yet recruiting - Conditions: Tuberculosis, Pulmonary; HIV/AIDS
Interventions: Drug: RIPE (2m) and RI (4m); Drug: RIPE+NAC (2m) and RI (4m)
Sponsor: Fundação de Medicina Tropical Dr. Heitor Vieira Dourado
Recruiting - Conditions: HIV/AIDS; Contraception
Intervention: Drug: etonogestrel implant
Sponsors: Catherine Chappell; Infectious Disease Institute, Kampala, Uganda; University of Nebraska
Not yet recruiting - Condition: Human Immunodeficiency Virus Infection
Interventions: Drug: Tenofovir Disoproxil Fumarate (TDF) 300 mg + Lamivudine (3TC) 300 mg + Efavirenz (EFV) 600 mg; Drug: Abacavir (ABC) 600 mg + Lamivudine (3TC) 300 mg + Efavirenz (EFV) 600 mg; Drug: Zidovudine (AZT) 300 mg + Lamivudine (3TC) 150 mg twice daily + Efavirenz (EFV) 600 mg once daily
Sponsors: Obafemi Awolowo University; Federal Medical Centre, Makurdi; University of Liverpool; University of California, San Diego; London School of Hygiene and Tropical Medicine
Recruiting - Conditions: HIV Infection; Drug Use
Intervention: Other: LINC-II
Sponsors: Boston Medical Center; National Institute on Drug Abuse (NIDA)
Not yet recruiting - Conditions: AIDS-Related Human Papillomavirus Infection; High Grade Cervical Squamous Intraepithelial Neoplasia; HIV Infection
Interventions: Other: Laboratory Biomarker Analysis; Biological: Recombinant Human Papillomavirus Nonavalent Vaccine; Other: Saline
Sponsors: AIDS Malignancy Consortium; National Cancer Institute (NCI); University of Arkansas; AIDS and Cancer Specimen Resource; Merck Sharp & Dohme Corp.; The EMMES Corporation; University of California, Los Angeles
Not yet recruiting - Condition: HIV-1
Interventions: Other: Classic evaluation of neurocognitive functions; Other: New evaluation of neurocognitive functions
Sponsor: Centre Hospitalier Universitaire de Nice
Recruiting - Condition: HIV Infections
Interventions: Behavioral: Quality improvement for PITC and partner referrals; Diagnostic Test: Self-testing for OPD and STI clients and partners
Sponsors: University of California, Los Angeles; Partners in Hope; United States Agency for International Development (USAID); Right to Care; Ministry of Health, Malawi
Recruiting - Condition: HIV/AIDS
Intervention:
Sponsors: Harvard School of Public Health; The Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD); National Institute on Drug Abuse (NIDA); National Institute of Allergy and Infectious Diseases (NIAID); The Office of AIDS Research (OAR); National Institute of Mental Health (NIMH); The National Institute of Neurological Disorders and Stroke (NINDS); The National Institute of Deafness and Other Communication Disorders (NIDCD); The National Institute of Dental and Craniofacial Research (NIDCR); National Institute on Alcohol Abuse and Alcoholism (NIAAA)
Not yet recruiting - Conditions: Alzheimer Disease; HIV
Intervention: Drug: F 18 T807
Sponsor: Washington University School of Medicine
Recruiting - Conditions: Risk Behavior; HIV/AIDS; Medication Adherence; Substance Abuse
Intervention: Other: CHRP-BB
Sponsors: University of Connecticut; National Institute on Drug Abuse (NIDA); APT Foundation, Inc.
Recruiting - Conditions: Hiv; Chlamydia; Gonorrhea
Interventions: Behavioral: 2GETHER; Behavioral: Existing Public Health Practice
Sponsor: Northwestern University
Not yet recruiting - Condition: HIV Associated Neurocognitive Disorder (HAND)
Interventions: Biological: IN insulin; Biological: IN saline
Sponsors: University of Calgary; Canadian Institutes of Health Research (CIHR); University of Alberta; Epidemiology Coordinating and Research Centre, Canada
Not yet recruiting - Conditions: HIV Infection; Alcohol Use; Pain
Interventions: Drug: Low dose naltrexone; Drug: Nalmefene
Sponsors: Boston Medical Center; National Institute on Alcohol Abuse and Alcoholism (NIAAA)
Not yet recruiting - Condition: HIV Prevention
Intervention: Behavioral: Value Affirmation and Future Selves Combination
Sponsors: Nichole Ben Itzhak; Allegheny Singer Research Institute; Gilead Sciences; University of Pittsburgh; Pittsburgh AIDS Task Force; Center for Inclusion Health; Central Outreach
Not yet recruiting - Conditions: Opioid-use Disorder; Hiv
Interventions: Drug: Naltrexone Injectable Suspension; Other: Treatment as usual
Sponsors: Oregon Health and Science University; National Institute on Drug Abuse (NIDA); Johns Hopkins University; University of Kentucky; Whitman-Walker Health; Jackson Health System; Sunshine Care Clinic; Tarzana Treatment Center; Ruth M. Rothstein CORE Center
Recruiting - Condition: HIV Prevention
Intervention: Drug: Tenofovir Disoproxil Fumarate/Emtricitabine
Sponsor: University of Nebraska
Recruiting - Condition: HIV-1 Infection
Interventions: Drug: MK-8591; Drug: Placebo to MK-8591; Drug: Doravirine; Drug: Placebo to Doravirine; Drug: Lamivudine; Drug: Placebo to Lamivudine; Drug: MK-1439A; Drug: Placebo to MK-1439A
Sponsor: Merck Sharp & Dohme Corp.
Recruiting - Condition: Infection, Human Immunodeficiency Virus
Intervention: Drug: Triumeq
Sponsors: Mills Clinical Research; ViiV Healthcare
Recruiting - Conditions: HIV/AIDS; Vitamin D Deficiency; Smoker Lung
Intervention: Drug: Vitamin D3 500,000 IU orally
Sponsor: Emory University
Recruiting - Condition: HIV Infections
Interventions: Drug: nPEP; Behavioral: Text Messaging Support; Other: Nurse-Led nPEP
Sponsors: St. Michael's Hospital, Toronto; Canadian Institutes of Health Research (CIHR); CIHR Canadian HIV Trials Network
Not yet recruiting - Condition: Human Immunodeficiency Virus I Infection
Intervention: Drug: Mycophenolate Mofetil 500Mg Tab
Sponsors: Fred Hutchinson Cancer Research Center; University of Washington
Recruiting - Conditions: Memory Impairment; HIV/AIDS; Cognitive Impairment
Intervention: Other: assessment of cognitive impairment
Sponsor: Fondation Ophtalmologique Adolphe de Rothschild
Recruiting - Conditions: HIV/AIDS; Periodontal Diseases
Intervention: Procedure: Basic periodontal treatment
Sponsor: University of Sao Paulo
Recruiting - Conditions: HIV; Zika Virus; Pregnant Women
Intervention:
Sponsors: Westat; Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD); National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting - Condition: HIV Negative People Identified at Substantial Risk for HIV Infection
Intervention: Other: PrEP Promotion Package
Sponsors: Clinton Health Access Initiative Inc.; Ministry of Health, Swaziland; Heidelberg University; Mylan Laboratories
Recruiting - Condition: Exposure to Sexually Transmissible Disorder (Event)
Interventions: Behavioral: Intervention; Behavioral: Individual evidence-based STI/HIV prevention intervention
Sponsors: Johns Hopkins University; Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Recruiting - Condition: HIV Infections
Intervention: Other: This study is non-interventional.
Sponsors: St Stephens Aids Trust; Public Health England; NHS England
Not yet recruiting - Condition: HIV
Intervention: Behavioral: disclosure-support counseling intervention
Sponsor: Yale University
Recruiting - Condition: HIV/AIDS
Intervention: Biological: CAR-T cells
Sponsors: Guangzhou 8th People's Hospital; Sun Yat-sen University
Not yet recruiting - Condition: HIV/AIDS
Intervention: Behavioral: WELL Program
Sponsors: Louisiana State University Health Sciences Center in New Orleans; National Institute on Alcohol Abuse and Alcoholism (NIAAA)
Recruiting - Condition: Human Immunodeficiency Virus
Intervention: Drug: 3BNC117-LS
Sponsor: Rockefeller University
Recruiting - Conditions: Preventive Medicine; HIV Infections
Intervention: Behavioral: RAMP PrEP initiation, adherence, and retention intervention
Sponsors: Brown University; University of Mississippi Medical Center
Recruiting - Conditions: HIV-1-infection; Pregnancy Related
Interventions: Drug: Dolutegravir; Drug: Standard of Care (EFV + 2 NRTI backbone)
Sponsors: University of Liverpool; UNITAID; University of Cape Town; Liverpool School of Tropical Medicine; Infectious Diseases Institute, Uganda; Radboud University
Recruiting - Conditions: Opioid Use; Marijuana; Chronic Pain; HIV/AIDS
Intervention:
Sponsors: Albert Einstein College of Medicine, Inc.; Fordham University; Columbia University
Not yet recruiting - Condition: HIV Infections
Intervention: Other: Cardiac MRI/MRS
Sponsors: Massachusetts General Hospital; National Heart, Lung, and Blood Institute (NHLBI); National Institutes of Health (NIH)
Recruiting - Condition: Uptake of HIVST-online
Intervention: Behavioral: HIVST-online promotion
Sponsor: Chinese University of Hong Kong
Recruiting - Condition: HIV Infections
Interventions: Drug: Dapivirine gel; Drug: Placebo gel
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting - Condition: HIV Associated HCV
Intervention: Other: blood draw
Sponsor: Assistance Publique Hopitaux De Marseille
Recruiting - Condition: HIV Infections
Intervention: Drug: Pembrolizumab
Sponsor: National Institute of Neurological Disorders and Stroke (NINDS)
Recruiting - Condition: HIV Prevention
Interventions: Drug: Tenofovir Disoproxil Fumarate (TDF)-Emtricitabine (FTC); Other: Placebo
Sponsors: Oak Crest Institute of Science; The Miriam Hospital; Johns Hopkins University; University of California, Los Angeles; University of California, San Diego; Vanderbilt University; The University of Texas Medical Branch, Galveston; National Institutes of Health (NIH); National Institute of Allergy and Infectious Diseases (NIAID)
Not yet recruiting - Condition: Human Immunodeficiency Virus
Intervention:
Sponsor: Columbia University
Recruiting - Condition: HIV
Interventions: Other: Parental Permission Required; Other: Adult permission required; Other: Autonomous consent
Sponsors: University of North Carolina, Chapel Hill; Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD); National Institute on Drug Abuse (NIDA); National Institute of Mental Health (NIMH); National Institute on Minority Health and Health Disparities (NIMHD)
Recruiting - Conditions: HIV-1-infection; Aging, Premature; Cognitive Impairment; Memory Impairment; HIV-Associated Cognitive Motor Complex
Interventions: Drug: Scopolamine Injectable Product; Drug: Mecamylamine Pill
Sponsor: Vanderbilt University Medical Center
Recruiting - Condition: Children Infected by HIV
Intervention:
Sponsor: French National Institute for Health and Medical Research-French National Agency for Research on AIDS and Viral Hepatitis (Inserm-ANRS)
Recruiting - Condition: Mother to Child Transmission of HIV
Intervention:
Sponsor: French National Agency for Research on AIDS and Viral Hepatitis
Recruiting - Condition: Hiv
Interventions: Drug: Hydrocortisone; Drug: Placebo Oral Tablet
Sponsors: Johns Hopkins University; National Institute of Mental Health (NIMH)
Not yet recruiting - Conditions: HIV/AIDS; Dried Blood Spot; Viral Load
Intervention: Other: Blood sample on DBS
Sponsors: Institut Pasteur; Global Fund; National Institute of Hygiene and Epidemiology, Vietnam; Hanoï University of Public Health; Institut National de la Santé Et de la Recherche Médicale, France
Recruiting - Conditions: HIV/AIDS; Cardiomyopathies
Intervention: Diagnostic Test: Echocardiogram
Sponsors: Duke University; Duke Center for AIDS Research; International AIDS Society; NIH Fogarty International Center
Recruiting - Condition: HIV/AIDS
Interventions: Other: Three month dispensing of ART in CARGs; Other: Six month dispensing of ART in CARGs
Sponsors: Kheth'Impilo; Ministry of Health and Child Care Zimbabwe (MOHCC); EQUIP Innovation for Health; Organization for Public Health Interventions and Development (OPHID); Family Health International (FHI 360); Population Services International (PSI)
Recruiting - Conditions: Adherence, Medication; HIV/AIDS
Intervention: Behavioral: Structured adherence counseling
Sponsors: Swiss Tropical & Public Health Institute; SolidarMed; Ministry of Health, Lesotho; University of Basel
Recruiting - Condition: HIV/AIDS Serodiagnosis
Interventions: Behavioral: Monetary Incentive; Behavioral: Information; Behavioral: Active Choice
Sponsors: Johns Hopkins University; Universidad San Francisco de Quito; University of South Florida
Recruiting - Condition: HIV Infections
Intervention: Other: Nevirapine plus lamivudine
Sponsor: Cantonal Hospital of St. Gallen
Recruiting - Conditions: HIV Lipodystrophy Syndrome; Growth Hormone Deficiency; Body Composition
Intervention: Drug: Tesamorelin
Sponsors: Columbia University; National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Recruiting - Condition: HIV-1-infection
Intervention: Drug: Truvada
Sponsors: University of KwaZulu; Centre for the AIDS Programme of Research in South Africa; Medical Research Council, South Africa
Recruiting - Condition: HIV Infections
Interventions: Biological: CH505TF; Biological: CH505w53; Biological: CH505w78; Biological: CH505w100; Biological: DNA Mosaic-Tre; Biological: GLA-SE adjuvant; Biological: Placebo
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting - Conditions: Pre-exposure Prophyalxis; HIV-1-infection
Intervention: Behavioral: Peer Navigation
Sponsor: Montefiore Medical Center
Not yet recruiting - Condition: HIV
Intervention:
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting - Conditions: Human Immunodeficiency Virus; Depression; Sexually Transmitted Diseases
Intervention: Behavioral: Our Family Our Future
Sponsors: Brown University; University of Cape Town; Desmond Tutu HIV Centre; Medical Research Council, South Africa; Rhode Island Hospital
Not yet recruiting - Condition: HIV II Infection
Intervention: Drug: Dolutegravir 50 mg
Sponsor: Blueclinical, Ltd.
Recruiting - Condition: HIV Infections
Intervention:
Sponsor: American Gene Technologies International Inc.
Recruiting - Condition: HIV Infections
Intervention: Other: questionnaires survey
Sponsor: Thai Red Cross AIDS Research Centre
Recruiting - Condition: HIV, Prophylaxis
Intervention: Drug: emtricitabine / tenofovir 200/300 mg
Sponsor: Oswaldo Cruz Foundation
Not yet recruiting - Condition: HIV-1 Infection
Interventions: Drug: Vorinostat; Biological: HXTC
Sponsors: University of North Carolina, Chapel Hill; National Heart, Lung, and Blood Institute (NHLBI)
Recruiting - Condition: Hepatitis B Vaccination, HIV
Intervention: Biological: Hepatitis B vaccine
Sponsor: Chiang Mai University
Recruiting - Condition: Infection, Human Immunodeficiency Virus
Interventions: Drug: GSK3640254; Drug: Placebo
Sponsors: ViiV Healthcare; GlaxoSmithKline
Recruiting - Condition: Prevention of Mother-to-child Transmission of HIV
Intervention:
Sponsors: University of Zimbabwe; NORHED
Recruiting - Condition: HIV Infections
Interventions: Biological: VRC01; Drug: Combination Antiretroviral Therapy (cART)
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Not yet recruiting - Condition: HIV-1-infection
Interventions: Combination Product: Dapivirine Vaginal Ring, 25 mg; Combination Product: Dapivirine Vaginal Ring, 100 mg; Combination Product: Dapivirine Vaginal Ring, 200 mg
Sponsors: International Partnership for Microbicides, Inc.; National Institutes of Health (NIH); National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting - Condition: Hiv
Interventions: Drug: Raltegravir 400Mg Tab; Drug: Lamivudine 150Mg Tablet
Sponsor: Guy's and St Thomas' NHS Foundation Trust
Not yet recruiting - Condition: HIV Infections
Interventions: Biological: PGDM1400/Placebo - 3mg/mL IV; Biological: PGDM1400/Placebo - 310mg/mL IV; Biological: PGDM1400/Placebo -30mg/mL IV; Biological: PGDM1400 + PGT121/Placebo - 3mg/mL + 3mg/mL IV; Biological: PGDM1400 + PGT121/Placebo - 10mg/mL + 10mg/mL IV; Biological: PGDM1400 + PGT121/Placebo - 30mg/mL + 30mg/mL IV; Biological: PGDM1400; Biological: PGDM1400+PGT121
Sponsors: International AIDS Vaccine Initiative; Beth Israel Deaconess Medical Center; Ragon Institute of MGH, MIT and Harvard
Recruiting - Condition: HIV/AIDS
Interventions: Drug: Maraviroc Pill; Drug: Dolutegravir Pill; Drug: Truvada Pill
Sponsors: University of North Carolina, Chapel Hill; National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting - Conditions: Substance Use Disorders; HIV; Depression
Intervention: Behavioral: Clinic-based screening and behavioral interventions
Sponsors: University of California, San Francisco; Kaiser Foundation Research Institute
Not yet recruiting - Condition: Human Immunodeficiency Virus
Intervention: Drug: Antiretrovirals
Sponsors: University of California, Los Angeles; Los Angeles LGBT Center; Tulane University
Recruiting - Condition: HIV Infections
Intervention:
Sponsors: Thai Red Cross AIDS Research Centre; amfAR, The Foundation for AIDS Research; TREAT Asia
Recruiting - Conditions: AIDS-Related Lymphoma; Ann Arbor Stage II Diffuse Large B-Cell Lymphoma; Ann Arbor Stage III Diffuse Large B-Cell Lymphoma; Ann Arbor Stage IV Diffuse Large B-Cell Lymphoma; CD20 Negative; CD20 Positive; HIV Positivity
Interventions: Drug: Cyclophosphamide; Drug: Doxorubicin Hydrochloride; Drug: Etoposide; Biological: Filgrastim; Drug: Ibrutinib; Other: Laboratory Biomarker Analysis; Biological: Pegfilgrastim; Other: Pharmacological Study; Drug: Prednisone; Biological: Rituximab; Drug: Vincristine Sulfate
Sponsor: National Cancer Institute (NCI)
Recruiting - Monitored Antiretroviral Pause in Chronic HIV-Infected Subjects With Long-Lasting Suppressed ViremiaCondition: HIV Seropositivity
Intervention: Other: Stop of ART
Sponsor: Ospedale San Raffaele
Recruiting - Conditions: Efavirenz; Child Behavior; Cognitive Symptom; Medication Adherence; Drug-Related Side Effects and Adverse Reactions
Interventions: Drug: Efavirenz-containing cART; Drug: Non-efavirenz containing cART
Sponsors: Radboud University; Kilimanjaro Christian Medical Centre, Tanzania; Kilimanjaro Clinical Research Institute
Recruiting - Condition: HIV/AIDS
Interventions: Device: Wise app with medication adherence reminders; Device: Wise app with fitness reminders
Sponsor: Columbia University
Recruiting - Condition: HIV/AIDS
Interventions: Other: Group A: Offline HTC; Other: Group B1: Offline HIV testing and post-test counseling; Other: Group B2: Online HIV testing and post-test counseling
Sponsors: Thai Red Cross AIDS Research Centre; amfAR GMT Implementation Research Grant
Recruiting - Conditions: Dyslipidemias; Cardiovascular Diseases; HIV Infections
Interventions: Drug: Alirocumab; Other: Placebo
Sponsors: University of California, San Francisco; Massachusetts General Hospital
Not yet recruiting - Conditions: AIDS-Related Opportunistic Infections; Meningoencephalitis; Cryptococcal Meningitis
Intervention:
Sponsors: St George's, University of London; European and Developing Countries Clinical Trials Partnership (EDCTP); National Institute for Medical Research, Tanzania; University of North Carolina Project-Malawi (UNC Project); French National Agency for Research on AIDS and Viral Hepatitis; Yaounde Central Hospital; Institut Pasteur
Recruiting - Conditions: HIV/AIDS; Contraception
Interventions: Combination Product: tenofovir/emtricitabine; Drug: DMPA
Sponsor: Jessica Tarleton
Recruiting - Condition: Virus-HIV
Intervention: Drug: Raltegravir and 2 Nucleoside/Nucleotide reverse transcriptase inhibitor (NRTI)
Sponsor: Nantes University Hospital
Recruiting - Conditions: HIV/AIDS; Albuminuria; Kidney Diseases; Genetic Predisposition
Interventions: Drug: Lisinopril; Other: Placebo Oral Tablet
Sponsors: Vanderbilt University Medical Center; National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); Aminu Kano Teaching Hospital; SAIC-Frederick, Inc.
Not yet recruiting - Condition: HIV Infections
Interventions: Behavioral: PRIDE; Behavioral: ePRIDE; Behavioral: Men's Health
Sponsors: San Francisco State University; University of California, San Francisco; University of Colorado, Denver; Johns Hopkins University
Recruiting - Condition: HIV
Intervention: Device: AlereCOMBO and Alere q Detect
Sponsors: Thai Red Cross AIDS Research Centre; Alere, Inc.
Recruiting - Conditions: HIV (Human Immunodeficiency Virus); AIDS (Acquired Immunodeficiency Syndrome)
Interventions: Behavioral: VIP app without HIV-related symptom strategies.; Behavioral: VIP app that delivers HIV-related symptom strategies.
Sponsors: Columbia University; National Institute of Nursing Research (NINR)
Recruiting - Condition: Human Immunodeficiency Virus
Intervention: Other: blood sample
Sponsors: University Hospital, Bordeaux; French National Institute for Health and Medical Research-French National Agency for Research on AIDS and Viral Hepatitis (Inserm-ANRS); Sidaction; Centre National de la Recherche Scientifique, France
Recruiting - Condition: Family Planning
Intervention: Other: WHO Decision-Making Tool for Family Planning Clients and Providers
Sponsors: University of Pennsylvania; National Institute of Allergy and Infectious Diseases (NIAID); University of Botswana
Recruiting - Condition: HIV-1-infection
Intervention: Behavioral: Mobile-enhanced Engagement Intervention
Sponsors: Johns Hopkins Bloomberg School of Public Health; National Institute on Drug Abuse (NIDA)
Recruiting - Condition: HIV/AIDS and Infections
Intervention: Behavioral: POSSE
Sponsor: John H. Stroger Hospital
Recruiting - Condition: HIV Infections
Interventions: Biological: p24CE1/2 pDNA Vaccine; Biological: p55^gag pDNA Vaccine; Biological: IL-12 pDNA Adjuvant; Biological: Placebo; Device: Ichor Medical Systems Intramuscular TriGrid Delivery System (TDS-IM) electroporation (EP) device
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting - Conditions: HIV/AIDS; TB - Tuberculosis; Antiretroviral Therapy, Highly Active
Interventions: Diagnostic Test: PLHIV Point of Care Xpert Ultra; Diagnostic Test: PLHIV Point of Care Xpert VL
Sponsor: University of Stellenbosch
Recruiting - Conditions: Hiv; Transgender Youth
Interventions: Behavioral: at-home test kit; Behavioral: Motivational Interviewing and Certified Testing and Referral
Sponsor: University of Michigan
Recruiting - Condition: HIV-1 Infection
Interventions: Drug: MK-8504 =< 240 mg; Drug: MK-8504 100 mg
Sponsor: Merck Sharp & Dohme Corp.
Recruiting - Conditions: HIV/AIDS; Sexually Transmitted Infection; Health Behavior
Intervention: Behavioral: GPS program
Sponsors: Ryerson University; Health Initiative for Men; Regional HIV/AIDS Connection; AIDS Committee of Toronto; Gay ZONE; The Ottawa Hospital; University of Victoria; University of Windsor; Ottawa Hospital Research Institute; Canadian Institutes of Health Research (CIHR); MAX Ottawa
Recruiting - Conditions: HIV Prevention; Conception
Intervention: Behavioral: PrEP for Safer Conception
Sponsors: Massachusetts General Hospital; National Institutes of Health (NIH); University of Witwatersrand, South Africa
Recruiting - Condition: Hiv
Intervention: Other: Adherence Clubs
Sponsors: University of Cape Town; Medical Research Council
Recruiting - Condition: Sexually Transmitted Infection
Intervention: Behavioral: ZETRA cognitive behavioral structural
Sponsors: University of California, San Francisco; University of Connecticut; MRC/UVRI Uganda Research Unit on Aids; National Institute of Mental Health (NIMH)
Recruiting - Condition: HIV-1-infection
Intervention: Other: no intervention
Sponsors: Hospital General Universitario Gregorio Marañon; University of California, Los Angeles; J Parrondo Health; Fundación para la Investigación Biomédica del Hospital Gregorio Maranon
Recruiting - Condition: Hiv
Intervention: Other: Adherence Club
Sponsors: University of Cape Town; Medical Research Council
Recruiting - Condition: HIV Infections
Intervention: Behavioral: MyPEEPS Mobile
Sponsors: Columbia University; University of Washington; Public Health Solutions; New York Blood Center; University of Alabama at Birmingham; Ann & Robert H Lurie Children's Hospital of Chicago; National Institute on Minority Health and Health Disparities (NIMHD)
Recruiting - Conditions: HIV; Awaiting Organ Transplant
Intervention:
Sponsor: University of Minnesota - Clinical and Translational Science Institute
Recruiting - Conditions: Hiv; Chlamydia; Gonorrhea; Relation, Interpersonal
Interventions: Behavioral: 2GETHER; Behavioral: Positive Affect Enhancement
Sponsors: Northwestern University; University of Cincinnati; Howard Brown Health Center
Not yet recruiting - Condition: Human Immunodeficiency Virus
Interventions: Other: HIV-infected Veterans who use MHV; Other: HIV-infected Veterans who do not use MHV
Sponsor: VA Palo Alto Health Care System
Not yet recruiting - Condition: Microbial Colonization
Intervention: Other: No intervention
Sponsors: Johns Hopkins University; University of Maryland
Recruiting - Conditions: Stimulant Abuse; HIV Prevention; Substance Abuse
Interventions: Behavioral: Time & Intensity Matched Control; Behavioral: IMPACT; Behavioral: Standard of Care
Sponsors: Brown University; University of Miami; The Fenway Institute
Recruiting - Condition: HIV Infections
Interventions: Drug: Oral CAB; Drug: Oral TDF/FTC; Drug: Placebo for oral CAB; Drug: Placebo for oral TDF/FTC; Drug: CAB LA; Drug: Placebo for CAB LA
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting - Conditions: HIV; Sexually Transmitted Diseases; Risk Reduction; Pre-Exposure Prophylaxis
Intervention: Behavioral: LYNX Mobile App
Sponsors: Public Health Foundation Enterprises, Inc.; Cook County Health & Hospitals System; Duke University; Emory University; Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD); San Francisco Department of Public Health; University of California, San Francisco; University of North Carolina, Chapel Hill; University of South Florida
Not yet recruiting - Condition: Human Immunodeficiency Virus
Interventions: Diagnostic Test: Oraquick HIV Self Test; Diagnostic Test: Clinic Based HIV Counseling and Testing (HCT)
Sponsors: University of North Carolina, Chapel Hill; University of Witwatersrand, South Africa; University of California, San Francisco; National Institutes of Health (NIH); Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Recruiting - Condition: HIV-1-infection
Intervention: Drug: 18F-Raltegravir
Sponsors: University of California, San Francisco; Merck Sharp & Dohme Corp.
Recruiting - Condition: HIV-1 Infection
Interventions: Biological: UB-421; Drug: Optimized background therapy (OBT)
Sponsor: United BioPharma
Not yet recruiting - Condition: HIV Infections
Intervention:
Sponsors: University of North Carolina, Chapel Hill; Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Recruiting - Condition: HIV-1-infection
Intervention: Genetic: CCR5 gene modification
Sponsors: Affiliated Hospital to Academy of Military Medical Sciences; Peking University; Capital Medical University
Recruiting - Conditions: HIV/AIDS; Dysbiosis; Inflammation
Interventions: Biological: Fecal Inoculum Capsule; Biological: Placebo (for Fecal Inoculum Capsule); Drug: Antibiotic; Drug: Antibiotic Placebo
Sponsor: Massachusetts General Hospital
Not yet recruiting - Conditions: HIV Infections; Zika Virus Infection
Intervention: Other: Biological sample collection
Sponsors: University Hospital Center of Martinique; University Hospital of Guadeloupe
Recruiting - Condition: HIV/AIDS
Intervention: Other: ACT
Sponsors: University of Nevada, Las Vegas; Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Recruiting - Conditions: HIV Seropositivity; CD4+ T Lymphocytopenia
Intervention: Other: Medical record review
Sponsors: Jena University Hospital; University of Magdeburg; University of Leipzig; University of Rostock; Center for Internal Medicine and Infectious Diseases, Munich; Prinzmed, Munich; Poliklinik GmbH, Chemnitz; Meddata GmbH, Sckeuditz; Technische Universität Dresden; Praxis Dr. Ruck, Leipzig; Praxis Dr. Ackermann, Halle; Praxis Dr. Lundershausen, Erfurt; MUC Research GmbH; Medcenter Weimar
Recruiting - Conditions: HIV/AIDS; Tuberculosis
Interventions: Other: Same-Day Treatment; Other: Standard treatment
Sponsors: Brigham and Women's Hospital; Haitian Group for the Study of Kaposi's Sarcoma and Opportunistic; Weill Medical College of Cornell University; Florida International University; University of California, Davis; Analysis Group, Inc.
Recruiting - Conditions: Sexual Behavior; Intimate Partner Violence
Intervention: Behavioral: Safe South Africa
Sponsors: Brown University; Medical Research Council, South Africa; Rhode Island Hospital
Not yet recruiting - Conditions: HIV; Sexually Transmitted Diseases; Pre-exposure Prophylaxis; Risk Reduction
Intervention: Behavioral: MyChoices
Sponsors: Brown University; Fenway Community Health; University of North Carolina; Montefiore Medical Center; Emory University
Recruiting - Condition: HIV-infection/AIDS
Intervention: Biological: Vedolizumab (brand name Entyvio)
Sponsors: Ottawa Hospital Research Institute; CHEO Research Institute; Nebraska Centre for Substance Abuse Research
Recruiting - Conditions: HIV-1-infection; Antiretroviral Therapy; Maintenance Therapy
Interventions: Drug: Switch to DTG + FTC; Other: Patient-centered monitoring
Sponsor: Calmy Alexandra
Recruiting - Condition: Human Immunodeficiency Virus
Intervention: Behavioral: Couples-based services
Sponsors: Vanderbilt University Medical Center; National Institute of Mental Health (NIMH)
Recruiting - Conditions: Kaposi Sarcoma; HIV
Intervention:
Sponsors: UNC Lineberger Comprehensive Cancer Center; National Cancer Institute (NCI)
Recruiting - Conditions: Kaposi Sarcoma; HIV Infections
Intervention: Drug: Tc99m-tilmanocept
Sponsors: Navidea Biopharmaceuticals; National Institutes of Health (NIH); National Cancer Institute (NCI)
Recruiting - Conditions: HIV Infections; HIV
Interventions: Behavioral: Information provision; Behavioral: Weekly quizzes; Behavioral: Rewards for testing HIV-negative
Sponsors: RAND; Columbia University; Bienestar Human Services, Inc.
Recruiting - Condition: HIV Infections
Interventions: Dietary Supplement: Curcumin; Dietary Supplement: Epigalocatequina 3 galate; Other: Placebo of Curcumin; Other: Placebo of Epigalocatequina 3 galate
Sponsor: Universidade Federal do Rio Grande do Norte
Not yet recruiting - Conditions: Thyroid; HIV Infections
Intervention: Other: Assay of TSH, FT3 and FT4 by immuno-radiometric method
Sponsor: Centre Hospitalier Universitaire, Amiens
Recruiting - Conditions: HIV Infections; Sexually Transmitted Diseases; Sexual Behavior; Adolescent Behavior; Homosexuality
Interventions: Behavioral: Life Skills Coaching; Behavioral: Community Resources
Sponsors: University of Pennsylvania; University of Michigan; Emory University; University of North Carolina; George Washington University; University of Minnesota - Clinical and Translational Science Institute
Recruiting - Condition: Safer Conception Intervention Trial
Intervention: Behavioral: safer conception counseling
Sponsors: RAND; Children's Mercy Hospital, University of Missouri, Kansas City; Makerere University; The AIDS Support Organization (TASO); University of Kansas
Recruiting - Conditions: Hiv; Neurocognitive Dysfunction
Intervention: Drug: emtricitabine, darunavir/cobicistat, maraviroc
Sponsor: Giovanni Di Perri
Recruiting - Condition: HIV-1 Infection
Interventions: Drug: UB-421; Drug: current standard HAART treatment
Sponsor: United BioPharma
Not yet recruiting - Conditions: HIV; Stress Disorder; Human Immunodeficiency Virus; Fatigue
Intervention: Behavioral: CBSM-SMI
Sponsors: Medical University of South Carolina; National Institute of Nursing Research (NINR)
Recruiting - Condition: HIV Infections
Interventions: Behavioral: YouTHrive; Behavioral: Information-only Control
Sponsors: University of Minnesota - Clinical and Translational Science Institute; University of North Carolina; University of Michigan; Emory University; Children's Hospital of Philadelphia; Texas Children's Hospital; Cook County Hospital; Montefiore Medical Center; University of South Florida
Recruiting - Conditions: Human Immunodeficiency Virus Infection; Inflammation
Interventions: Behavioral: AWARENESS for Sexual Minorities; Behavioral: Writing tasks
Sponsor: University of California, San Francisco
Recruiting - Conditions: HIV Infections; Hiv
Interventions: Diagnostic Test: Standard of Care Testing Clinic Participants; Diagnostic Test: Alere Q Testing Clinic Participants
Sponsors: University of Alabama at Birmingham; Centre for Infectious Disease Research in Zambia; Centers for Disease Control and Prevention
Not yet recruiting - Condition: Patient Non-compliance
Intervention:
Sponsors: Centre for the AIDS Programme of Research in South Africa; Columbia University
Recruiting - Condition: Human Immunodeficiency Virus
Intervention: Behavioral: Provision of multiple self-tests
Sponsors: University of Pennsylvania; National Institute of Mental Health (NIMH); Impact Research & Development Organization; RTI International
Recruiting - Condition: HIV Infections
Intervention: Biological: Yellow Fever vaccination (17 DD Biomanguinhos)
Sponsor: Oswaldo Cruz Foundation
Recruiting - Conditions: Tuberculosis; HIV Infections
Interventions: Drug: Delamanid; Drug: Optimized multidrug background regimen (OBR) for children with MDR-TB
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting - Condition: HIV/AIDS
Intervention: Behavioral: Praise message phone call
Sponsors: Reed College; Population Services International; United States Agency for International Development (USAID)
Recruiting - Condition: Fracture Healing in HIV-positive Patients
Intervention: Other: HIV positive patients
Sponsors: Wellcome Trust Liverpool Glasgow Centre for Global Health Research; Professor David Lalloo; Professor Hamish Simpson; Professor William J Harrison; Professor Sithombo Maqungo
Not yet recruiting - Condition: HIV Infection
Intervention:
Sponsor: University Hospital, Strasbourg, France
Recruiting - Conditions: HIV Infections; Autoimmune Diseases Affecting Skin
Intervention: Diagnostic Test: Blood Sampling
Sponsor: Medical University of Vienna
Recruiting - Condition: HIV-1-infection
Intervention: Biological: blood sampling
Sponsor: French National Institute for Health and Medical Research-French National Agency for Research on AIDS and Viral Hepatitis (Inserm-ANRS)
Recruiting - Condition: HIV Seropositivity
Intervention: Other: Neuromuscular tests
Sponsor: Centre Hospitalier Universitaire de Nice
Not yet recruiting - Condition: Esophageal Squamous Cell Carcinoma
Intervention:
Sponsor: UNC Lineberger Comprehensive Cancer Center
Recruiting - Condition: HIV Infections
Interventions: Biological: ALVAC-HIV (vCP2438); Biological: Bivalent subtype C gp120/MF59; Biological: Bivalent subtype C gp120/AS01(B); Biological: Placebo
Sponsors: National Institute of Allergy and Infectious Diseases (NIAID); GlaxoSmithKline; Sanofi Pasteur, a Sanofi Company
Recruiting - Conditions: HIV Prevention; Sexually Transmitted Diseases; Pre-Exposure Prophylaxis
Interventions: Behavioral: HOME Study intervention; Behavioral: Control
Sponsors: Public Health Foundation Enterprises, Inc.; National Institute of Allergy and Infectious Diseases (NIAID); San Francisco Department of Public Health; University of California, San Francisco
Recruiting - Conditions: HIV/AIDS; Hepatitis C; Substance Use Disorders; Opioid-use Disorder
Interventions: Other: Information Control; Other: HIV and HCV Testing Practice Coaching Intervention; Other: HIV Testing Practice Coaching Intervention
Sponsors: Columbia University; National Institute on Drug Abuse (NIDA); Weill Medical College of Cornell University; University of Miami; Johns Hopkins University; Boston Medical Center; Medical University of South Carolina; Research Foundation for Mental Hygiene, Inc.; San Francisco Department of Public Health; Aspire Health Partners
Recruiting - Condition: HIV/AIDS
Interventions: Behavioral: Control Arm; Behavioral: iSTEP
Sponsor: University of California, San Diego
Recruiting - Conditions: Hiv; Healthy
Intervention: Other: Observational
Sponsor: University of Pennsylvania
Recruiting - Conditions: HIV; Mental Health; Substance Use; STI
Interventions: Behavioral: Automated Messaging & Monitoring; Behavioral: Peer Support; Behavioral: Coaching
Sponsors: University of California, Los Angeles; Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD); Tulane University Health Sciences Center; University of California, San Francisco; Friends Research Institute, Inc.
Recruiting - Condition: HIV Prevention
Intervention: Other: PrEP-R Supportive Contact
Sponsors: University of Chicago; Howard Brown Health Center; Ann & Robert H Lurie Children's Hospital of Chicago; National Institute of Mental Health (NIMH)
Not yet recruiting - Condition: HIV Infections
Interventions: Behavioral: Get Connected; Behavioral: AIDSVu
Sponsors: University of Pennsylvania; University of North Carolina; University of Michigan; University of Minnesota - Clinical and Translational Science Institute; Emory University; Children's Hospital of Philadelphia; Texas Children's Hospital
Recruiting - Condition: HIV
Intervention:
Sponsors: Hospital General Universitario Gregorio Marañon; Merck Sharp & Dohme Corp.; SERMAS; Molecular-Clinical Pharmacol/Instit.Translational Medicine/University Liverpool
Not yet recruiting - Conditions: Hepatic Steatosis; HIV-1-infection
Interventions: Drug: Maraviroc; Drug: Metformin
Sponsors: University College, London; Medical Research Council; ViiV Healthcare; Royal Free Hospital NHS Foundation Trust
Recruiting - Condition: HIV Infections
Intervention: Drug: PrEP with Truvada®
Sponsor: French National Institute for Health and Medical Research-French National Agency for Research on AIDS and Viral Hepatitis (Inserm-ANRS)
Recruiting - Condition: HIV Prevention
Interventions: Behavioral: Narrative Exposure Therapy (NET); Behavioral: Motivational Interviewing w/Skills Training (MIST)
Sponsors: University of Washington; National Institute on Minority Health and Health Disparities (NIMHD)
Recruiting - Condition: HIV-1-infection
Interventions: Other: For Step 2: Structured treatment interruption; Procedure: Peripheral blood draw
Sponsor: Washington University School of Medicine
Recruiting - Condition: HIV and Hepatitis B Coinfection
Intervention: Drug: Tenofovir Alafenamide
Sponsor: University Hospital Inselspital, Berne
Recruiting - Condition: Human Immunodeficiency Virus
Interventions: Drug: TMB-607; Drug: Placebo
Sponsor: Temple University
Recruiting - Conditions: Hepatitis C; HIV Coinfection
Interventions: Drug: LDV/SOF and TAF; Drug: Tenofovir alafenamide 25mg/emtricitabine 200mg (Descovy); Drug: Experimental: Ledipasvir 90mg/sofosbuvir 400mg (Harvoni)
Sponsor: University of Colorado, Denver
Recruiting - Conditions: Risk Reduction; HIV; Sexually Transmitted Infections (Not HIV or Hepatitis)
Intervention: Behavioral: Sex Pro mobile Application
Sponsors: Public Health Foundation Enterprises, Inc.; National Institute of Mental Health (NIMH); San Francisco Department of Public Health; University of California, San Francisco
Not yet recruiting - Condition: HIV
Interventions: Behavioral: HIV Self-Testing; Behavioral: Immediate Access to ART for HIV infected couple members; Behavioral: Access to PrEP for HIV uninfected couple members
Sponsors: Medical University of South Carolina; National Institute of Mental Health (NIMH)
Recruiting - Conditions: HIV; Mental Health; Illicit Substance Use; Sexually Transmitted Infections (STI)
Interventions: Behavioral: Level 1; Behavioral: Level 2; Behavioral: Level 3
Sponsors: University of California, Los Angeles; Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD); Wake Forest University Health Sciences; Tulane University Health Sciences Center; Columbia University
Recruiting - Conditions: Physical Activity; HIV Infections
Intervention: Behavioral: Physical Activity
Sponsors: Scientific Institute San Raffaele; University of Milan; Catholic University of the Sacred Heart; IRCCS Lazzaro Spallanzani; University of Roma La Sapienza
Recruiting - Condition: HIV-1-infection
Interventions: Other: Three-month ART dispensing; Other: Six-month ART dispensing
Sponsors: University of California, Los Angeles; Boston University; Equip, Lesotho; Ministry of Health, Malawi; Ministry of Health, Zambia; Partners in Hope; Right to Care; United States Agency for International Development (USAID)
Recruiting - Conditions: HIV-Associated Cognitive Motor Complex; Aging; Cognitive Impairment; Cognitive Decline; Attention Impaired; Processing, Visual Spatial; Cognitive Deficit in Attention; Cognitive Disorder in Remission
Interventions: Behavioral: Individualized Cognitive Training; Other: No-Contact Control
Sponsors: University of Alabama at Birmingham; National Institute of Nursing Research (NINR)
Recruiting - Conditions: Human Immunodeficiency Virus; Diabetes Mellitus, Type 2; Hypertension
Interventions: Diagnostic Test: Blood glucose and blood pressure testing; Behavioral: Diet and lifestyle counseling; Drug: DM/HTN medications as needed
Sponsors: Medical University of South Carolina; National Institute of Mental Health (NIMH); Muhimbili University of Health and Allied Sciences
Recruiting - Condition: HIV
Intervention: Device: HIV medication adherence app
Sponsors: Children's Hospital of Philadelphia; National Institute of Mental Health (NIMH); National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting - Conditions: Cannabis; HIV Neuropathy; Pain Syndrome
Intervention: Drug: Cannabis
Sponsor: Barth Wilsey MD
Not yet recruiting - Conditions: HIV; Cancer
Intervention: Drug: Durvalumab
Sponsor: Spanish Lung Cancer Group
Recruiting - Condition: Human Immunodeficiency Virus I Infection
Intervention: Drug: Darunavir
Sponsors: Université Catholique de Louvain; Cliniques universitaires Saint-Luc- Université Catholique de Louvain
Recruiting - Conditions: HIV Dementia; HIV-Associated Cognitive Motor Complex
Interventions: Drug: Insulin, intranasal; Drug: Placebo, intranasal
Sponsor: Johns Hopkins University
Recruiting - Conditions: HIV; Insulin Sensitivity; Diabetes Mellitus
Interventions: Drug: Zidovudine; Drug: Nevirapine
Sponsors: Icahn School of Medicine at Mount Sinai; National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Recruiting - Condition: HIV/AIDS
Intervention: Other: switch
Sponsors: Swiss Tropical & Public Health Institute; Prof. Manuel Battegay, Study Chair, University Hospital Basel; Bienvenu Nsakala, MD, Co-Investigator & Study Physician SolidarMed; Josephine Muhairwe, MD, MPH, Co-Investigator & Country Coordinator SolidarMed; Tracy Glass, PhD, Co-Investigator & Statistician SwissTPH; Fiona Vanobberghen, PhD, Co-Investigator & Statistician SwissTPH; Prof. Thomas Klimkait, PhD, Co-Investigator, Department of Biomedicine, University of Basel; Beatrice Achieng, Study nurse & Clinical Officer, Butha-Buthe Hospital, Lesotho; Mamorena Sepeka, Study nurse, Butha-Buthe Hospital, Lesotho; Katleho Tlali, MLS, Laboratory Technician Laboratory Butha-Buthe Hospital, Lesotho; Lebohang Sao, MD, District Health Manager Butha-Buthe, Lesotho; Kyaw Thin, MD & MPH, Head of Research Coordination Unit, Ministry of Health Lesotho
Recruiting - Conditions: Tuberculosis; Tuberculous Meningitis; Drug-Induced Liver Injury; HIV; IRIS
Interventions: Drug: Dexamethasone; Other: Placebo
Sponsors: Oxford University Clinical Research Unit, Vietnam; Pham Ngoc Thach Hospital, Ho Chi Minh City, Vietnam; Hospital for Tropical Diseases, Ho Chi Minh City, Vietnam; Cipto Mangunkusumo Hospital, Jakarta, Indonesia; RSUP Persahabatan Hospital, Jakarta, Indonesia; Eijkman Oxford Clinical Research Unit, Indonesia
Recruiting - Conditions: Opioid Dependence; Addiction; HIV/AIDS; Tuberculosis; Hepatitis
Interventions: Drug: Naltrexone; Drug: Methadone; Drug: Isoniazid; Drug: Rifapentine
Sponsors: Yale University; University of Malaya; National Institute on Drug Abuse (NIDA)
Recruiting - Conditions: HIV; Medication Adherence
Interventions: Behavioral: Tel-me-box with reminder features; Behavioral: Tel-me-box
Sponsors: University of California, San Francisco; National Institute of Mental Health (NIMH)
Not yet recruiting - Condition: HIV/AIDS
Interventions: Behavioral: Traditional Healer Support Program; Drug: Standard of Care
Sponsors: Vanderbilt University Medical Center; National Institute of Mental Health (NIMH)
Recruiting - Conditions: HIV-1-infection; Pneumocystis Pneumonia; Opportunistic Infections; Preventive Therapy; Antibiotic Side Effect
Interventions: Drug: Cotrimoxazole; Drug: Placebo
Sponsors: University of Bergen; Haukeland University Hospital; Muhimbili University of Health and Allied Sciences; Helse Vest
Recruiting - Condition: HIV Infections
Interventions: Drug: ELV/COBI/FTC/TAF; Drug: DTG/3TC/ABC + ELV/COBI/FTC/TAF
Sponsor: Fundacion SEIMC-GESIDA
Not yet recruiting - Condition: Herpesvirus
Intervention:
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting - Condition: HIV Prevention
Intervention: Drug: DuoGel
Sponsors: Johns Hopkins University; ImQuest Pharmaceuticals, Inc.; National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting - Condition: HIV-1
Interventions: Biological: Ad26.Mos4.HIV; Biological: Clade C gp140; Biological: Placebo
Sponsor: Janssen Vaccines & Prevention B.V.
Recruiting - Condition: HIV
Intervention: Drug: 3BNC117-Copper-64
Sponsors: Bayside Health; The Peter Doherty Institute for Infection and Immunity; Monash University; Monash Health; Rockefeller University; Austin Health
Not yet recruiting - Conditions: Obstructive Sleep Apnea; HIV/AIDS
Intervention:
Sponsors: University of California, San Diego; Center For AIDS Research Creative and Novel Ideas in HIV Research (CFAR CNIHR)
Recruiting - Condition: At Risk for HIV
Intervention: Device: PrEP Smart app
Sponsors: Duke University; Intelligent Automation, Inc.
Recruiting - Conditions: HIV/AIDS; Cognitive Impairment; Aging; Mobility Limitation; Medication Adherence; Depression; Quality of Life; Balance Problems
Intervention: Other: Yoga-mindfulness
Sponsors: Adria Quigley; Canadian Institutes of Health Research (CIHR)
Recruiting - Conditions: HIV Infections; Pregnancy Related
Interventions: Drug: Universal PrEP Counseling; Drug: Targeted PrEP Counseling
Sponsors: University of Washington; Kenyatta National Hospital; National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting - Evaluate the Safety and Efficacy of Vesatolimod in Antiretroviral Treated HIV-1 Infected ControllersCondition: HIV-1 Infection
Interventions: Drug: Vesatolimod; Drug: Vesatolimod Placebo; Drug: ART
Sponsor: Gilead Sciences
Recruiting - Condition: HIV
Intervention: Behavioral: Financial incentive
Sponsors: University of Washington; Kenyatta National Hospital; University of Nairobi
Recruiting - Condition: HIV Infections
Interventions: Drug: Dolutegravir; Drug: Emtricitabine/tenofovir alafenamide; Drug: Emtricitabine/tenofovir disoproxil fumarate; Drug: Efavirenz/emtricitabine/tenofovir disoproxil fumarate
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting - Conditions: HIV; Substance Use
Intervention: Behavioral: Vr2L 2Spirit
Sponsors: University of Washington; National Institute on Drug Abuse (NIDA)
Recruiting - Condition: Infection, Human Immunodeficiency Virus
Interventions: Drug: GSK2838232; Drug: Cobicistat
Sponsor: GlaxoSmithKline
Recruiting - Condition: PrEP Adherence Monitoring
Intervention: Drug: tenofovir disoproxil and emtricitabine
Sponsor: Rutgers, The State University of New Jersey
Recruiting - Conditions: HIV Infections; Transgender Women
Intervention: Other: No Intervention for both groups
Sponsors: Thai Red Cross AIDS Research Centre; amfAR, The Foundation for AIDS Research
Recruiting - Condition: HIV Prevention
Intervention: Drug: Tenofovir Disoproxil Fumarate/Emtricitabine
Sponsor: Johns Hopkins University
Recruiting - Condition: HIV Infections
Intervention: Drug: ARV treatment
Sponsors: The Huesped Foundation; ViiV Healthcare
Recruiting - Condition: HIV
Interventions: Drug: Raltegravir; Drug: Placebo; Drug: Current ART
Sponsors: Fundacio Lluita Contra la SIDA; Merck Sharp & Dohme Corp.
Recruiting - Condition: HIV Infections
Interventions: Drug: N(t)RTIs; Drug: Dolutegravir; Drug: Darunavir; Drug: Ritonavir
Sponsors: Kirby Institute; UNITAID; National Health and Medical Research Council, Australia; ViiV Healthcare; Janssen Pharmaceutica
Recruiting - Condition: Hiv
Intervention: Biological: Autologous CD4 T-Cells
Sponsor: University of Pennsylvania
Recruiting - Condition: Compensated Cirrhosis
Interventions: Drug: Grazaoprevir/Elbasavir; Drug: Grazaoprevir/Elbasavir/RBV
Sponsors: The HIV Netherlands Australia Thailand Research Collaboration; Chulalongkorn University; Merck Sharp & Dohme Corp.
Not yet recruiting - Condition: Infection, Human Immunodeficiency Virus
Interventions: Drug: Dolutegravir film-coated tablets; Drug: Dolutegravir film-coated dispersible tablets
Sponsor: ViiV Healthcare
Recruiting - Condition: Cervical Cancer
Intervention: Behavioral: Health-Literacy Focused Education Session
Sponsor: Johns Hopkins University
Recruiting - Conditions: Adolescents; HIV/AIDS; Patient Adherence
Intervention: Combination Product: Tailored realtime triggered reminder pkg
Sponsors: University of New England; Institute of Population, Health and Development, Vietnam; Boston University
Not yet recruiting - Condition: HIV Seropositivity
Interventions: Behavioral: Telephone-Administered Motivational Interviewing Plus Behavioral Skills Training; Behavioral: Telephone-Administered Coping Effectiveness Training
Sponsors: Oregon Health and Science University; University of Georgia; Hunter College of City University of New York
Recruiting - Condition: Leishmaniasis, Visceral
Intervention: Other: No intervention
Sponsors: Institute of Tropical Medicine, Belgium; University of Gondar, Gondar, Ethiopia; Medecins Sans Frontieres, Netherlands; Bureau of Health, Abdurafi, Ethiopia
Recruiting - Condition: HIV-1 Infection
Intervention: Drug: Antiretroviral treatment pause
Sponsors: AIDS Clinical Trials Group; National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting - Conditions: HIV Infections; Health Volunteers
Interventions: Drug: ABX464 150mg; Drug: ABX464 50mg
Sponsors: Abivax S.A.; FLS-RS
Recruiting - Condition: HIV
Intervention: Other: Systems Analysis and Improvement Approach
Sponsors: University of Washington; National Institutes of Health (NIH); University of Nairobi; Kenyatta National Hospital; Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD); Ministry of Health, Mombasa County
Not yet recruiting - Condition: HIV Infections
Interventions: Drug: Truvada; Drug: Genvoya
Sponsors: Emory University; Centers for Disease Control and Prevention
Recruiting - Condition: HIV-1 Infection
Interventions: Drug: Dolutegravir; Drug: Darunavir-cobicistat; Drug: Emtricitabine-Tenofovir
Sponsors: French National Institute for Health and Medical Research-French National Agency for Research on AIDS and Viral Hepatitis (Inserm-ANRS); Institut National de la Santé Et de la Recherche Médicale, France
Recruiting - Conditions: Smoking Cessation; HIV
Interventions: Other: Combination Therapy; Other: Standard Care Intervention
Sponsors: dr. maria miguez; University of Miami
Recruiting - Conditions: Hiv; Kidney Transplant; HIV Reservoir; CCR5
Intervention: Drug: Sirolimus + Maraviroc
Sponsor: University of Maryland
Recruiting - Condition: HIV Infections
Interventions: Biological: ALVAC-HIV (vCP2438); Biological: Bivalent Subtype C gp120/MF59; Biological: Placebo
Sponsors: National Institute of Allergy and Infectious Diseases (NIAID); Sanofi; GlaxoSmithKline; Bill and Melinda Gates Foundation
Recruiting - Condition: HIV Infections
Interventions: Behavioral: Incentives; Behavioral: Integrated Care Centers
Sponsors: Johns Hopkins University; National Institute on Drug Abuse (NIDA); YR Gaitonde Centre for AIDS Research and Education; Elton John AIDS Foundation
Recruiting - Conditions: Condomless Sex; Human Immunodeficiency Virus (HIV); Sexually Transmitted Infections (STIs); Alcohol and Drug Use; Violence and Victimization; Access and Linkage to Healthcare; Education Advancement
Interventions: Behavioral: Young Women's Health CoOp (YWHC); Behavioral: Standard HTC
Sponsors: RTI International; South African Medical Research Council, SAMRC
Recruiting - Condition: Hiv
Intervention:
Sponsor: IrsiCaixa
Not yet recruiting - Condition: Hiv
Interventions: Procedure: Anoscopy with Rectal Tissue Sampling; Procedure: Phlebotomy; Procedure: Female Genital Tract Sampling
Sponsor: University of North Carolina, Chapel Hill
Recruiting - Conditions: Condomless Sex; Human Immunodeficiency Virus (HIV); Sexually Transmitted Infection (STI); Alcohol and Drug Use
Interventions: Behavioral: Face-to-Face Women's CoOp (WC); Behavioral: mHealth Women's CoOp (WC); Behavioral: HIV Counseling and Testing
Sponsors: RTI International; Durham County Department of Public Health; Guilford County Department of Public Health; Wake County Human Services
Recruiting - Strategic Screening for Infectious Diseases (Tuberculosis, HIV, HBV, HCV) Amongst Migrants in FranceConditions: HIV; Hepatitis C; Hepatitis B; Tuberculosis
Intervention:
Sponsor: University Paris 7 - Denis Diderot
Recruiting - Condition: HIV
Intervention: Drug: Ixazomib
Sponsors: Mayo Clinic; Takeda
Recruiting - Condition: HIV
Intervention: Behavioral: Harnessing Online Peer Education (HOPE) Social Media Intervention
Sponsor: University of California, Los Angeles
Recruiting - Conditions: HIV; Partner Violence; Malnutrition; Alcohol Use/Abuse; Depression
Interventions: Behavioral: Accountable Condition; Behavioral: Control Condition
Sponsors: University of California, Los Angeles; National Institute of Mental Health (NIMH); University of Stellenbosch
Recruiting - Conditions: HIV Positive; Alcohol Use
Interventions: Behavioral: Computerized Brief Intervention (CBI); Behavioral: CBT4CBT; Drug: Recommendation and Counseling for Alcohol Pharmacotherapy
Sponsor: University of Alabama at Birmingham
Recruiting - Condition: HIV Infections
Interventions: Drug: Tenofovir; Drug: Lamivudine; Drug: Efavirenz
Sponsors: Shanghai Public Health Clinical Center; The Second Hospital of Nanjing; Yunnan Provincial Infectious Disease Hospital
Recruiting - A Unified Intervention for Young Gay and Bisexual Men's Minority Stress, Mental Health, and HIV RiskConditions: HIV; Acquired Immunodeficiency Syndrome
Interventions: Behavioral: ESTEEM; Behavioral: CMHT; Behavioral: VCT
Sponsor: Yale University
Recruiting - Conditions: Impaired Cognition; HIV Infection
Intervention: Behavioral: MBSR
Sponsors: University of California, San Francisco; National Institute of Nursing Research (NINR); Harvard School of Public Health; Northwestern University; University of Missouri, St. Louis; Washington University School of Medicine
Recruiting - Condition: Stress
Intervention: Behavioral: Mindful Living With Stress
Sponsors: Central South University; University of California, Los Angeles
Recruiting - Condition: HIV Infection
Interventions: Behavioral: N'ap Grandi; Behavioral: N'ap Grandi - A; Behavioral: Health Promotion - A
Sponsor: Florida International University
Recruiting - Conditions: HIV; Tuberculosis
Intervention: Other: Test and treat
Sponsors: University of North Carolina, Chapel Hill; Department for International Development, United Kingdom
Recruiting - Condition: HIV/AIDS
Interventions: Behavioral: DuoPACT; Behavioral: LifeSteps
Sponsor: University of California, San Francisco
Recruiting - Condition: HIV Infection
Interventions: Drug: P2G12 Dose Cohort 1; Drug: P2G12 Dose Cohort 2; Drug: P2G12 Dose Cohort 3
Sponsor: St George's, University of London
Not yet recruiting - Condition: HIV Infections
Interventions: Biological: DNA-HIV-PT123 vaccine; Biological: Bivalent Subtype C gp120/MF59 vaccine; Biological: Bivalent Subtype C gp120/AS01B vaccine; Biological: Placebo
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting - Condition: HIV
Interventions: Drug: dolutegravir; Drug: Triumeq; Drug: Truvada
Sponsors: Emory University; National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting - Condition: HIV Infections
Intervention: Other: mHealth platform
Sponsors: Hospital Clinic of Barcelona; Brighton and Sussex University Hospitals NHS Trust; Instituut Voor Tropische Geneeskunde (ITM), Antwerp, Belgium.; Klinika za infektivne bolesti (KIB), Zagreb, Croatia; Centro Hospitalar de Lisboa Central; Fundacion Clinic per a la Recerca Biomédica; University of Brighton; Podmedics, ( POD), Northwood, United Kingdom; Universidad Politecnica de Madrid; National Prospective Monitoring System HIV Health-economics Collaboration, (NPMS), Richmond, United Kingdom; European Aids Treatment Group (EATG), Brussels, Belgium; mHealth Futures LTD, Brighton, United Kingdom
Recruiting - Condition: AIDS/HIV
Intervention: Behavioral: Cognitive Behavioral Therapy
Sponsor: University of Massachusetts, Boston
Recruiting - Conditions: Tuberculosis; HIV Infections
Intervention: Drug: Bedaquiline
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting - Conditions: HIV; ART
Interventions: Other: ART initiation in the home; Other: Mobile Van Refill and Monitoring; Other: Clinic ART Initiation; Other: Clinic ART Refill and Monitoring
Sponsors: University of Washington; Bill and Melinda Gates Foundation
Recruiting - Conditions: HIV; Alcohol Use Disorders
Intervention: Other: Transitional HIV care for prison releasees
Sponsors: University of North Carolina, Chapel Hill; National Institutes of Health (NIH); John E. Fogarty International Center (FIC)
Recruiting - Conditions: Cocaine Use Disorders; HIV
Interventions: Device: Active Cognitive Training (ACT); Device: Control Training (CON)
Sponsor: Duke University
Recruiting - Condition: HIV/AIDS
Interventions: Other: Prize incentive - Low; Other: Prize incentive - High; Other: Escalating payment incentive; Other: Travel Voucher; Other: Standard care; Behavioral: Fixed Incentive - Prize; Behavioral: Loss Aversion - Prize; Behavioral: Lottery - Prize; Behavioral: Fixed Incentive - Voucher; Behavioral: Loss Aversion - Deposit
Sponsors: University of California, San Francisco; University of North Carolina, Chapel Hill; Makerere University; National Institute of Mental Health (NIMH)
Recruiting - Conditions: Bacterial Vaginosis; HIV
Interventions: Drug: Norethisterone enantate; Device: Condoms
Sponsors: London School of Hygiene and Tropical Medicine; Imperial College London; University of Liverpool; MRC/UVRI Uganda Research Unit on Aids
Recruiting - Conditions: Insomnia; HIV
Intervention: Behavioral: CBT-I
Sponsor: Ryerson University
Recruiting - Condition: Substance-related Disorders
Intervention: Behavioral: Implementation Facilitation
Sponsors: Yale University; National Institute on Drug Abuse (NIDA)
Recruiting - Conditions: Acute Hepatitis C; HIV
Intervention: Drug: Grazoprevir/Elbasvir
Sponsors: Institut de Médecine et d'Epidémiologie Appliquée - Fondation Internationale Léon M'Ba; Merck Sharp & Dohme Corp.; Institut National de la Santé Et de la Recherche Médicale, France
Recruiting - Condition: HIV
Interventions: Behavioral: Mindfulness Training (MT); Behavioral: Health Coaching (HC)
Sponsors: The Miriam Hospital; National Center for Complementary and Integrative Health (NCCIH)
Recruiting - Conditions: HIV; AIDS
Interventions: Behavioral: Educational Intervention (EI); Behavioral: Peer Transition Advocate (PTA)
Sponsor: University of Maryland
Not yet recruiting - Conditions: Hepatitis C; Human Immunodeficiency Virus
Intervention: Drug: Maraviroc
Sponsors: University of Maryland; ViiV Healthcare
Recruiting - Condition: HIV Infection
Interventions: Drug: Griffithsin Gel; Drug: Placebo Gel
Sponsor: Population Council
Recruiting - Conditions: HIV; Diastolic Dysfunction; Myocardial Fibrosis
Intervention: Other: Cardiac MRI/MRS
Sponsors: Massachusetts General Hospital; President and Fellows of Harvard College
Recruiting - Condition: HIV Infection
Intervention: Other: additional blood sample
Sponsor: Centre Hospitalier Universitaire de Besancon
Recruiting - Condition: HIV
Intervention: Drug: prescription of at least one of the following drugs: rilpivirine, elvitegravir, dolutegravir
Sponsor: Fondation Ophtalmologique Adolphe de Rothschild
Not yet recruiting - Condition: Amphetamine Use Disorders
Interventions: Drug: Oxytocin; Drug: Placebo
Sponsor: University of California, San Francisco
Recruiting - Condition: HIV Prevention
Intervention: Drug: Dapivirine Vaginal Ring-004
Sponsor: International Partnership for Microbicides, Inc.
Recruiting - Condition: HIV
Intervention: Drug: PRO 140
Sponsor: CytoDyn, Inc.
Recruiting - Conditions: HIV; STI
Intervention: Drug: TDF/FTC
Sponsor: Kirby Institute
Recruiting - Condition: HIV Disease
Intervention: Drug: Pyridostigmine
Sponsors: Icahn School of Medicine at Mount Sinai; National Institutes of Health (NIH); National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Recruiting - Conditions: Human Immunodeficiency Virus (HIV); Human Papillomavirus (HPV)
Interventions: Procedure: Perianal and Digital Anorectal Exam; Procedure: Cervical Swabs; Procedure: Anal Swabs; Procedure: High Resolution Anoscopy (HRA)
Sponsor: Emory University
Recruiting - Condition: HIV-1 Infection
Intervention: Drug: elvitegravir/cobicistat/emtricitabine/tenofovir alafenamide or other medically-appropriate FDA-approved antiretroviral therapy
Sponsors: AIDS Clinical Trials Group; National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting - Conditions: HIV; Inflammation
Intervention: Dietary Supplement: Zinc gluconate
Sponsors: Grace McComsey; National Institutes of Health (NIH)
Recruiting - Conditions: Lung Inflammation; HIV Seropositivity
Interventions: Other: ECIGS; Behavioral: mobile contingency management (mCM); Other: Usual brand
Sponsors: Duke University; National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting - Condition: Human Immunodeficiency Virus (HIV)
Interventions: Drug: 3BNC117; Drug: Romidepsin
Sponsors: Rockefeller University; University Hospital of Cologne; Aarhus University Hospital
Recruiting - Condition: Human Immunodeficiency Virus
Intervention: Combination Product: Dapivirine Vaginal Ring
Sponsor: International Partnership for Microbicides, Inc.
Recruiting - Condition: HIV-1
Intervention: Biological: VRC-HIVMAB080-00-AB (VRC01LS)
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting - Conditions: HIV Infection; Coronary Heart Disease
Interventions: Drug: Pravastatin; Drug: Rosuvastatin
Sponsor: Matthew Feinstein
Recruiting - Condition: Subjects With Hyperlipidemia, Dyslipidemia and HIV Infection
Interventions: Drug: Repatha (Evolocumab); Drug: Placebo
Sponsor: Amgen
Recruiting - Conditions: Pregnancy; Human Immunodeficiency Virus; Sexually Transmitted Diseases
Interventions: Behavioral: enhanced group support; Behavioral: enhanced individual support
Sponsors: Johns Hopkins University; MU-JHU CARE
Recruiting - Condition: Human Immunodeficiency Virus (HIV)
Interventions: Drug: 3BNC117; Drug: 10-1074; Other: Analytical treatment interruption; Drug: Placebo
Sponsors: Rockefeller University; University Hospital of Cologne
Recruiting - Conditions: Malignant Neoplasms of Mesothelial and Soft Tissue; Human Immunodeficiency Virus
Interventions: Behavioral: Screening Interview; Device: Carbon Monoxide Test; Behavioral: Self-Help Materials; Procedure: Visual Oral Screening Examination; Procedure: Direct Fluorescent Oral Visualization Examination; Procedure: Oral Biopsy
Sponsors: M.D. Anderson Cancer Center; Baylor College of Medicine; The University of Texas Health Science Center, Houston
Recruiting - Condition: HIV
Intervention:
Sponsor: Centre de Recherches et d'Etude sur la Pathologie Tropicale et le Sida
Recruiting - Condition: HIV
Interventions: Drug: Efavirenz; Drug: tenofovir /emtricitabine; Drug: tenofovir/lamivudine; Drug: lamivudine/zidovudine; Drug: Rifinah or local generics
Sponsors: St Stephens Aids Trust; Mylan Inc.; United States Agency for International Development (USAID)
Recruiting - Conditions: HIV; Smoking
Interventions: Behavioral: Counseling; Drug: Smoking Cessation drugs; Procedure: Bronchoscopy; Procedure: Blood Draw; Behavioral: Questionnaires
Sponsors: Boston Medical Center; National Institute on Drug Abuse (NIDA)
Recruiting - Conditions: Osteoporosis; HIV; Menopause
Interventions: Drug: tenofovir-alafenamide-emtricitabine; Drug: tenofovir-emtricitabine
Sponsors: University Health Network, Toronto; University of Modena and Reggio Emilia; San Raffaele University Hospital, Italy; Gilead Sciences; CIHR Canadian HIV Trials Network
Not yet recruiting - Condition: HIV Infections
Interventions: Biological: VRC01; Biological: VRC01LS
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting - Condition: Human Immunodeficiency Virus
Intervention:
Sponsors: University of Colorado, Denver; National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting - Conditions: HIV Infection; Alcohol Use; Smoking
Interventions: Drug: Varenicline; Drug: Cytisine; Drug: Nicotine Replacement Therapy; Drug: Varenicline Placebo; Drug: Cytisine Placebo; Drug: Nicotine Replacement Therapy Placebo
Sponsors: Boston Medical Center; National Institute on Alcohol Abuse and Alcoholism (NIAAA)
Recruiting - Condition: HIV
Intervention: Device: Oraquick (made in Thailand)
Sponsors: London School of Hygiene and Tropical Medicine; Zambart; Society for Family Health, Zambia; Liverpool School of Tropical Medicine; University College, London; Population Services International; World Health Organization; UNITAID
Recruiting - Condition: HIV
Intervention: Biological: Entyvio (Vedolizumab)
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting - Conditions: Human Immunodeficiency Virus (HIV) Infection; Hypercholesterolemia
Interventions: Other: Soy Pretzel; Other: Wheat Pretzel
Sponsor: Ohio State University
Recruiting - Conditions: Human Immunodeficiency Virus; Substance Abuse, Intravenous
Intervention: Other: BRIDGE
Sponsors: Columbia University; National Institute on Drug Abuse (NIDA)
Recruiting - Conditions: Hepatitis C; HIV
Intervention:
Sponsors: Macfarlane Burnet Institute for Medical Research and Public Health Ltd; The Alfred
Recruiting - Conditions: HIV/AIDS; Medication Adherence
Intervention: Device: Proteus digital health feedback (PDHF) system
Sponsors: University of California, Los Angeles; Yale University; University of Nebraska
Recruiting - Conditions: HIV Infection; Mature T-Cell and NK-Cell Non-Hodgkin Lymphoma; Plasmablastic Lymphoma; Recurrent Adult Hodgkin Lymphoma; Recurrent Adult Non-Hodgkin Lymphoma; Recurrent Burkitt Lymphoma; Recurrent Follicular Lymphoma; Stage III Follicular Lymphoma; Stage III Mantle Cell Lymphoma; Stage IV Follicular Lymphoma; Stage IV Mantle Cell Lymphoma
Interventions: Procedure: Autologous Hematopoietic Stem Cell Transplantation; Drug: Carmustine; Drug: Cytarabine; Drug: Etoposide; Other: Laboratory Biomarker Analysis; Biological: Lentivirus Vector CCR5 shRNA/TRIM5alpha/TAR Decoy-transduced Autologous CD34-positive Hematopoietic Progenitor Cells; Drug: Melphalan; Procedure: Peripheral Blood Stem Cell Transplantation
Sponsors: AIDS Malignancy Consortium; National Cancer Institute (NCI)
Recruiting - Condition: HIV Infections
Intervention: Drug: Maraviroc
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting - Conditions: HIV; AIDS
Intervention: Procedure: HIV-1 RNA Resistance Testing
Sponsors: Massachusetts General Hospital; Mbarara University of Science and Technology; University of KwaZulu; Emory University; University of Rochester; National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting - Conditions: Hepatitis C; HIV
Interventions: Drug: grazoprevir/elbasvir, ribavirin; Behavioral: Behavioural Intervention
Sponsor: University of Zurich
Recruiting - Condition: HIV
Interventions: Drug: Cyanocobalamin; Drug: Folate; Drug: Pyridoxine
Sponsor: Göteborg University
Recruiting - Conditions: Hepatocellular Carcinoma; HIV; Chronic Hepatitis C; Hepatitis B Virus; Liver Cirrhosis
Intervention:
Sponsor: Hospital Universitario de Valme
Recruiting - Condition: HIV Infection
Interventions: Biological: DCV3; Biological: DCV3 with PEG-INF; Biological: Placebo; Biological: Placebo with PEG-INF
Sponsor: Judit Pich Martínez
Recruiting - Condition: HIV CDC Category A1
Interventions: Behavioral: Mzake ndi Mzake T1; Behavioral: Mzake ndi Mzake T2; Behavioral: Mzake ndi Mzake T3
Sponsors: University of Illinois at Chicago; Kamuzu College of Nursing, University of Malawi
Recruiting - Conditions: HIV; Depression; Pain
Interventions: Behavioral: HIVPASS; Behavioral: Health Education
Sponsor: Butler Hospital
Recruiting - Condition: HIV
Intervention:
Sponsors: South East Asia Research Collaboration with Hawaii; US Military HIV Research Program
Recruiting - Conditions: HIV; Cognition - Other; Impaired Driving
Interventions: Behavioral: Speed of Processing Training; Other: Internet Navigational
Sponsor: University of Alabama at Birmingham
Recruiting - Condition: HIV Prevention
Interventions: Drug: Tenofovir enema; Other: Saline enema
Sponsors: Johns Hopkins University; University of California, Los Angeles; University of Pittsburgh
Recruiting - Condition: HIV Infection
Interventions: Drug: ART initiation at time of HIV diagnosis; Drug: ART at 24 weeks
Sponsors: Fred Hutchinson Cancer Research Center; University of California, San Francisco; University of Washington; Asociación Civil Impacta Salud y Educación, Peru; Université de Montréal; Seattle Children's Hospital
Recruiting - Condition: HIV, Hepatitis B, Hepatitis C and Syphilis Infections
Interventions: Behavioral: Computer-assisted counseling; Behavioral: On-demand counseling; Behavioral: Standard counseling; Behavioral: Appointment + reminder; Behavioral: Reminder; Behavioral: No appointment and no reminder
Sponsors: Institut de Recherche pour le Developpement; Chiang Mai University; Expertise France
Recruiting - Conditions: HIV Infections; Kidney Diseases
Interventions: Drug: Maraviroc; Drug: Placebo
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting - Condition: HIV
Interventions: Behavioral: Experimental Intervention (STEP-AD); Behavioral: Enhanced Treatment as Usual (E-TAU)
Sponsors: University of Miami; Massachusetts General Hospital; National Institute of Mental Health (NIMH)
Recruiting - Conditions: Fistula; HIV
Intervention:
Sponsors: University of North Carolina, Chapel Hill; Baylor College of Medicine
Recruiting - Condition: HIV
Interventions: Drug: Eplerenone; Drug: Placebo; Behavioral: Lifestyle Modification
Sponsor: Massachusetts General Hospital
Recruiting - Conditions: Cerebrovascular Accident, Acute; HIV
Intervention: Other: stroke center referral
Sponsor: Fondation Ophtalmologique Adolphe de Rothschild
Recruiting - Conditions: HIV; Adolescent Behavior
Interventions: Behavioral: SMART Randomization 1 - Referral; Behavioral: SMART Randomization 1 - Referral and SMS; Behavioral: SMART Randomization 2 - SMS; Behavioral: SMART Randomization 2 - Incentive; Behavioral: High Risk Negative Cohort (N=185); Other: All participants. Approximately (N=1200)
Sponsors: Yale University; Kenyatta National Hospital; Impact Research & Development Organization; National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting - Conditions: Dengue Fever; Dengue Hemorrhagic Fever; Human Immunodeficiency Virus
Interventions: Biological: CYD Dengue Vaccine; Biological: Placebo (NaCl 0.9%) vaccine group
Sponsor: Sanofi Pasteur, a Sanofi Company
Not yet recruiting - Conditions: HIV Infection; Diabetes Mellitus Type 2; Obesity; Overweight; Metabolic Syndrome
Intervention: Drug: Liraglutide
Sponsors: Temple University; The Comprehensive NeuroAIDS Center (CNAC) at Temple University
Recruiting - Condition: HIV-1 Infection
Intervention:
Sponsor: Kirby Institute
Recruiting - Condition: HIV Transmission, Transtheoretical Model of Change
Interventions: Behavioral: PS-PrEP Intervention Group; Behavioral: PrEPLine Control Group
Sponsor: University of Chicago
Recruiting - Conditions: Sexual Abstinence; HIV; Contraceptive Usage
Intervention: Behavioral: ITG (In This Together)
Sponsors: Center for Innovative Public Health Research; Internet Solutions for Kids Uganda
Recruiting - Condition: HIV Infections
Interventions: Drug: Cabotegravir tablets; Drug: TDF/FTC tablets; Drug: TDF/FTC placebo tablets; Drug: CAB placebo tablets; Drug: CAB LA; Drug: Placebo for CAB LA
Sponsors: National Institute of Allergy and Infectious Diseases (NIAID); ViiV Healthcare; Gilead Sciences
Recruiting - Condition: HIV
Interventions: Device: OraQuick ADVANCE HIV I/II test kits, packaged for self-use (manufactured in Thailand); Other: Home-based initiation of ARVs
Sponsors: London School of Hygiene and Tropical Medicine; UNITAID; Malawi-Liverpool-Wellcome Trust Clinical Research Programme; Liverpool School of Tropical Medicine; University College, London; Population Services International; World Health Organization
Recruiting - Condition: HIV Infections
Interventions: Biological: VRC01; Biological: Placebo for VRC01
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting - Condition: HIV Testing
Interventions: Behavioral: PB-HCT +; Behavioral: PB-HCT -; Behavioral: Economic incentive; Behavioral: PB-HCT ++; Behavioral: SMS Reminder
Sponsors: University of South Carolina; Duke University; Kilimanjaro Christian Medical Centre, Tanzania
Recruiting - Conditions: HIV; Substance Abuse
Intervention: Behavioral: Women's Health CoOp (WHC)
Sponsors: RTI International; Kheth'Impilo
Recruiting - Condition: HIV/AIDS and Infections
Interventions: Drug: Zidovudine; Drug: Nevirapine; Drug: Lamivudine; Drug: Lopinavir/ritonavir
Sponsors: National Center for Women and Children's Health, China CDC; National Center for AIDS/STD Control and Prevention, China CDC; Maternal and Child Health Hospital of Yunan Province; Maternal and Child Health Hospital of Sichuan Province; Maternal and Child Health Hospital of Guangxi Province; Maternal and Child Health Hospital of Xinjiang Uygur Autonomous Region; Guangdong Provincial Maternal and Child Health Hospital
Recruiting - Condition: HIV-1 Infection
Interventions: Drug: Vorinostat; Biological: AGS-004
Sponsors: University of North Carolina, Chapel Hill; National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting - Conditions: HIV; Cardiovascular Disease; AIDS
Interventions: Behavioral: Let's Move Program; Behavioral: Let's Flex Program; Behavioral: Group Motivational Interviewing
Sponsor: Emory University
Recruiting - Condition: HIV
Interventions: Drug: ibalizumab; Drug: Optimized Background Regimen
Sponsors: TaiMed Biologics Inc.; Westat
Recruiting - Conditions: Alcohol Drinking; HIV
Interventions: Behavioral: Motivational intervention; Behavioral: Brief Advice; Behavioral: Interactive text messaging
Sponsor: Brown University
Recruiting - Condition: HIV Infection
Interventions: Behavioral: Social Network-Based Adherence Intervention; Behavioral: Social Media Platform
Sponsors: University of California, Los Angeles; The Fenway Institute; Brown University; Asociación Civil Impacta Salud y Educación, Peru
Recruiting - Conditions: HIV; Substance Use
Interventions: Behavioral: Alcohol Use BI; Behavioral: Nutrition Intervention
Sponsors: Ann & Robert H Lurie Children's Hospital of Chicago; National Institute on Drug Abuse (NIDA)
Recruiting - Condition: HIV Infection
Intervention: Drug: Anti-HIV Agents
Sponsors: University of Nebraska; University of Minnesota - Clinical and Translational Science Institute
Not yet recruiting - Conditions: Human Immunodeficiency Virus; Depression; Mental Health
Intervention: Behavioral: Cognitive Behavioral Therapy
Sponsors: University of Miami; National Institute of Mental Health (NIMH); National Institute on Drug Abuse (NIDA)
Recruiting - Condition: HIV Prevention
Intervention: Behavioral: In-depth Interview (IDIs) or Focus Group Discussion (FGD)
Sponsors: Microbicide Trials Network; National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting - Conditions: Liver Cirrhosis; Hepatocellular Carcinoma; HIV; HCV Coinfection
Intervention:
Sponsors: Hospital Universitario de Valme; Hospital Universitario Virgen Macarena; Complejo Hospitalario Universitario de Huelva; Hospital de La Línea; Hospital Universitario Reina Sofia de Cordoba; Hospital Universitario Virgen de la Victoria; Complejo Hospitalario de Jaén; Hospital Universitario de Puerto Real
Recruiting - Conditions: Immunodeficiency Virus, Human; Depressive Symptoms
Intervention: Behavioral: Cognitive Behavioral Therapy for Adherence and Depression
Sponsors: University of Miami; Massachusetts General Hospital; University of Cape Town; National Institute of Mental Health (NIMH)
Recruiting - Condition: Early Infant HIV Diagnosis
Interventions: Device: DNA PCR HIV diagnostic test; Device: Alere Q
Sponsors: University of North Carolina, Chapel Hill; National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting - Condition: HIV
Intervention: Behavioral: PrEP Intervention
Sponsors: University of Chicago; University of Athens; National Development and Research Institutes, Inc.
Recruiting - Condition: HIV Infection
Intervention: Other: Blood draw
Sponsor: French National Institute for Health and Medical Research-French National Agency for Research on AIDS and Viral Hepatitis (Inserm-ANRS)
Recruiting - Condition: HIV
Interventions: Behavioral: Exercise; Behavioral: Stretching and Social Interaction
Sponsors: Washington University School of Medicine; University of Missouri, St. Louis; University of California, San Diego
Recruiting - Condition: HIV
Intervention: Biological: Cohort HIVOL, patients infected by HIV
Sponsor: Centre Hospitalier Universitaire de Saint Etienne
Recruiting - Conditions: HIV Infection; Aging
Intervention:
Sponsor: University of Modena and Reggio Emilia
Recruiting - Condition: Human Immunodeficiency Virus
Intervention: Drug: dolutegravir/abacavir/lamivudine
Sponsors: University College Dublin; Mater Misericordiae University Hospital; ViiV Healthcare
Not yet recruiting - Condition: HIV
Interventions: Drug: Dolutegravir; Drug: Emtricitabine/Tenofovir
Sponsors: University of California, San Francisco; ViiV Healthcare; Gilead Sciences
Recruiting - Conditions: Human Immunodeficiency Virus; Disorder of Immune Reconstitution
Intervention: Combination Product: Conventional plus AAIT
Sponsor: Beijing 302 Hospital
Recruiting - Conditions: Diffuse Large B-cell Lymphoma; HIV
Intervention: Drug: R-CHOP
Sponsors: UNC Lineberger Comprehensive Cancer Center; John E. Fogarty International Center (FIC); National Institutes of Health (NIH); National Cancer Institute (NCI)
Recruiting - Conditions: Depression; HIV; AIDS
Interventions: Drug: Escitalopram; Other: Placebo
Sponsor: University of Pennsylvania
Recruiting - Condition: HIV
Interventions: Procedure: Upper endoscopy; Procedure: Anoscopy; Drug: Truvada
Sponsor: University of Washington
Recruiting - Conditions: Coronary Artery Disease; Human Immunodeficiency Virus
Interventions: Drug: Colchicine; Drug: Placebo
Sponsors: Johns Hopkins University; National Heart, Lung, and Blood Institute (NHLBI)
Recruiting - Condition: HIV/AIDS
Intervention: Behavioral: Individualized, interactive short messaging intervention
Sponsors: University of Washington; University of Nairobi; Kenya Medical Research Institute
Recruiting - Condition: HIV-1 Infection
Intervention: Drug: E/C/F/TAF
Sponsor: Gilead Sciences
Recruiting - Condition: HIV
Interventions: Other: Agrarian Diet; Other: Western-type Diet
Sponsor: University of Colorado, Denver
Recruiting - Condition: HIV Infection
Interventions: Other: Adaptive WM CogMed Training; Other: Nonadaptive WM CogMed Training
Sponsors: University of Hawaii; National Institute on Drug Abuse (NIDA); University of Maryland
Recruiting - Condition: Hepatitis C
Interventions: Drug: SOF/VEL for 6 weeks; Drug: SOF/VEL for 12 weeks
Sponsor: Kirby Institute
Recruiting - Condition: HIV
Interventions: Drug: dolutegravir 50mg +abacavir 600mg +lamivudine 300mg; Drug: dolutegravir
Sponsor: Centre Hospitalier Régional d'Orléans
Recruiting - Condition: HIV-1 Infections
Intervention: Drug: TDF/FTC
Sponsor: MRC/UVRI Uganda Research Unit on Aids
Recruiting - Conditions: HIV; Hepatitis C
Intervention:
Sponsors: University of California, Los Angeles; Merck Sharp & Dohme Corp.
Recruiting - Condition: HIV Infections
Interventions: Biological: VRC01; Biological: Placebo for VRC01; Drug: Antiretroviral therapy (ART) (regimen will vary within countries and by patient)
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting - Conditions: AIDS-Related Non-Hodgkin Lymphoma; Classical Hodgkin Lymphoma; HIV Infection; Locally Advanced Malignant Neoplasm; Metastatic Malignant Neoplasm; Recurrent Hepatocellular Carcinoma; Recurrent Hodgkin Lymphoma; Recurrent Kaposi Sarcoma; Recurrent Malignant Neoplasm; Recurrent Melanoma of the Skin; Recurrent Non-Hodgkin Lymphoma; Recurrent Non-Small Cell Lung Carcinoma; Refractory Hodgkin Lymphoma; Refractory Malignant Neoplasm; Solid Neoplasm; Stage IIIA Cutaneous Melanoma AJCC v7; Stage IIIA Hepatocellular Carcinoma AJCC v7; Stage IIIA Non-Small Cell Lung Cancer AJCC v7; Stage IIIB Cutaneous Melanoma AJCC v7; Stage IIIB Hepatocellular Carcinoma AJCC v7; Stage IIIB Non-Small Cell Lung Cancer AJCC v7; Stage IIIC Cutaneous Melanoma AJCC v7; Stage IIIC Hepatocellular Carcinoma AJCC v7; Stage IV Cutaneous Melanoma AJCC v6 and v7; Stage IV Non-Small Cell Lung Cancer AJCC v7; Stage IVA Hepatocellular Carcinoma AJCC v7; Stage IVB Hepatocellular Carcinoma AJCC v7
Interventions: Other: Laboratory Biomarker Analysis; Biological: Pembrolizumab
Sponsor: National Cancer Institute (NCI)
Recruiting - Conditions: HIV; Herpes Simplex Infections
Interventions: Drug: MB66; Drug: Placebo Film
Sponsors: LeafBio, Inc.; National Institute of Allergy and Infectious Diseases (NIAID); Boston University; The Miriam Hospital
Recruiting - Condition: HIV Infections
Interventions: Biological: VRC01; Biological: Placebo for VRC01
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting - Condition: HIV Prevention
Interventions: Behavioral: Text Messaging; Behavioral: Adherence Counseling; Drug: Daily Oral PrEP
Sponsors: University of California, Los Angeles; California Collaborative Treatment Group; University of California, San Diego; California HIV/AIDS Research Program; Los Angeles County Department of Public Health; AIDS Project Los Angeles
Recruiting - Conditions: Tuberculosis; HIV Infections
Interventions: Drug: Bedaquiline; Drug: Delamanid; Drug: Dolutegravir
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting - Condition: HIV
Intervention: Biological: HIV-specific CD8 cells
Sponsors: Guangzhou 8th People's Hospital; Sun Yat-sen University
Recruiting - Conditions: Alcohol Consumption; HIV; Motivation
Interventions: Behavioral: Motivational Interviewing; Other: Questionnaire assessment; Other: Neurocognitive assessments; Other: Blood specimens
Sponsors: University of Florida; National Institute on Alcohol Abuse and Alcoholism (NIAAA)
Recruiting - Condition: HIV
Interventions: Behavioral: HealthScouts; Other: Standard of Care
Sponsor: Johns Hopkins University
Recruiting - Conditions: HIV; Human Immunodeficiency Virus
Intervention: Drug: Euphorbia kansui extract powder prepared as tea
Sponsors: University of California, San Francisco; Center for AIDS Research (CFAR); amfAR, The Foundation for AIDS Research
Not yet recruiting - Conditions: Human Immunodeficiency Virus; Acquired Immune Deficiency Syndrome Virus; Liver Diseases; Liver Cirrhosis; Fibrosis
Intervention:
Sponsor: Oswaldo Cruz Foundation
Recruiting - Condition: HIV
Interventions: Behavioral: Taking It to the Pews (Comparison); Behavioral: Taking It to the Pews (Experimental)
Sponsors: University of Missouri, Kansas City; City of Kansas City Missouri Health Department; Kansas City CARE Clinic; RAND; Children's Mercy Hospital Kansas City; Caanon Worship Center; Christian Fellowship Baptist Church; Friendship Baptist Church; JayDoc Free Clinic; Metropolitan Spiritual Church of Christ; NBC Community Development Corporation; Concord Fortress of Hope Church; Victorious Life Church; Calvary Community Outreach Network
Recruiting - Conditions: HIV; Hepatitis C; Cirrhosis
Intervention: Drug: Harvoni
Sponsors: University of California, San Francisco; National Institute of Allergy and Infectious Diseases (NIAID); Icahn School of Medicine at Mount Sinai; Columbia University; University of Pennsylvania; University of Maryland; Georgetown University; Johns Hopkins University; National Institutes of Health Clinical Center (CC)
Recruiting - Condition: HIV Infections
Interventions: Drug: Placebo for maraviroc (MVC); Drug: Placebo for dolutegravir (DTG); Drug: Dolutegravir (DTG); Drug: Maraviroc (MVC)
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting - Condition: HIV
Intervention: Genetic: SB-728mR-HSPC Infusion 3 days following busulfan conditioning
Sponsors: City of Hope Medical Center; Sangamo Therapeutics
Recruiting - Condition: Human Immunodeficiency Virus Type 1
Intervention: Drug: Rilpivirine
Sponsor: Janssen Sciences Ireland UC
Recruiting - Condition: HIV Infection
Intervention: Other: Dolutegravir in a dual therapy regimen
Sponsor: Asociacion para el Estudio de las Enfermedades Infecciosas
Recruiting - Condition: HIV-Infection
Interventions: Drug: Prezista; Drug: Norvir; Drug: Tivicay; Drug: Truvada; Drug: Kivexa
Sponsor: Technische Universität München
Recruiting - Reducing the Residual Reservoir of HIV-1 Infected Cells in Patients Receiving Antiretroviral TherapyCondition: HIV Infection
Interventions: Drug: Panobinostat; Drug: Pegylated Interferon-alpha2a
Sponsors: Massachusetts General Hospital; Novartis; Genentech, Inc.
Recruiting - Condition: HIV-1 Infection
Intervention: Drug: Atazanavir 200 mg/r
Sponsors: Centre de Recherches et d'Etude sur la Pathologie Tropicale et le Sida; INSERM UMR S 1136
Recruiting - Condition: Infection, Human Immunodeficiency Virus
Interventions: Drug: Cabotegravir tablet 30 mg once daily for 28 days.; Drug: Cabotegravir injection 3 mL (200 mg/mL) IM given once on Day 1.
Sponsor: ViiV Healthcare
Recruiting - Condition: Human Immunodeficiency Virus
Interventions: Behavioral: Enhanced Adherence Package; Other: Standard of Care
Sponsors: University of North Carolina, Chapel Hill; Centre for Infectious Disease Research in Zambia; Centers for Disease Control and Prevention
Recruiting - Conditions: Smoking; HIV
Interventions: Drug: Varenicline; Behavioral: Positively Smoke Free; Drug: Placebo; Behavioral: Standard of Care
Sponsor: University of Maryland
Recruiting - Conditions: Acute HIV Infection; HIV Seropositive; Sexually Transmitted Infections
Intervention: Other: Notification cards
Sponsors: University of North Carolina, Chapel Hill; National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting - Conditions: Bacterial Vaginosis; HIV
Intervention: Drug: NuvaRing
Sponsors: University of Washington; Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Recruiting - Condition: HIV-1 Infection
Interventions: Drug: Visbiome; Other: Placebo
Sponsors: University Health Network, Toronto; CIHR Canadian HIV Trials Network
Recruiting - Conditions: Adverse Bone Health; HIV Infection
Interventions: Dietary Supplement: High dose vitamin D and calcium; Dietary Supplement: Normal dose vitamin D and calcium
Sponsors: Chiang Mai University; HIV-NAT, Thai Red Cross - AIDS Research Centre; Nakornping Hospital, Chiang Mai
Recruiting - Conditions: Anal Squamous Cell Carcinoma; HIV Infection; Stage 0 Anal Canal Cancer; Stage I Anal Canal Cancer
Intervention: Procedure: Therapeutic Conventional Surgery
Sponsors: AIDS Malignancy Consortium; National Cancer Institute (NCI); The EMMES Corporation
Recruiting - Conditions: Chronic Lung Disease; HIV Infection
Interventions: Drug: Azithromycin; Drug: Placebo
Sponsors: London School of Hygiene and Tropical Medicine; Biomedical Research and Training Institute, Zimbabwe; Malawi-Liverpool-Wellcome Trust Clinical Research Programme; University of Tromso; University of Cape Town; University of Oxford
Recruiting - Condition: AIDS-Related Dementia Complex
Intervention: Other: Optical Coherence Tomography
Sponsors: Centre Hospitalier Universitaire Saint Pierre; Fonds iris-Recherche, Fondation Roi Baudouin, Belgium
Recruiting - Condition: HIV
Interventions: Drug: Nevirapine; Drug: Zidovudine; Drug: Lamivudine; Drug: LPV/r
Sponsors: Columbia University; National Institutes of Health (NIH); University of Witwatersrand, South Africa; Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Recruiting - Conditions: HIV; Communicable Diseases; Hepatitis B; HBV; Infectious Diseases
Interventions: Drug: Engerix B; Drug: Fendrix
Sponsor: Sheffield Teaching Hospitals NHS Foundation Trust
Recruiting - Conditions: HIV; Tuberculosis
Interventions: Drug: Lopinavir/r will be supplied by NHSO/GPO; Drug: Rifabutin
Sponsors: The HIV Netherlands Australia Thailand Research Collaboration; Bamrasnaradura Infectious Diseases Institute; Chulalongkorn University
Recruiting - Conditions: Advanced Malignant Solid Neoplasm; Anal Carcinoma; HIV Infection; Kaposi Sarcoma; Lung Carcinoma; Metastatic Malignant Solid Neoplasm; Recurrent Classical Hodgkin Lymphoma; Refractory Classical Hodgkin Lymphoma; Unresectable Solid Neoplasm
Interventions: Biological: Ipilimumab; Other: Laboratory Biomarker Analysis; Biological: Nivolumab
Sponsor: National Cancer Institute (NCI)
Recruiting - Condition: HIV
Interventions: Other: HIV positive subjects; Other: Non-infected control subjects
Sponsors: University of Florida; Janet K. Yamamoto Donor Fund
Recruiting - Condition: HIV
Interventions: Drug: vorapaxar; Drug: Placebo
Sponsors: Kirby Institute; National Institute of Allergy and Infectious Diseases (NIAID); University of Minnesota - Clinical and Translational Science Institute; University of Melbourne; Merck Sharp & Dohme Corp.
Recruiting - Conditions: HIV; Acute HIV Infection
Intervention: Drug: DTG/3TC/ABC FDC
Sponsors: University of North Carolina, Chapel Hill; ViiV Healthcare
Recruiting - Condition: HIV Infection
Interventions: Drug: DTG +DRV/r; Drug: SOC
Sponsor: PENTA Foundation
Recruiting - Condition: HIV
Interventions: Behavioral: Website A; Other: Website B
Sponsors: Centre hospitalier de l'Université de Montréal (CHUM); Canadian Institutes of Health Research (CIHR); CIHR Canadian HIV Trials Network
Recruiting - Conditions: HIV; Contraception
Interventions: Drug: Depot medroxyprogesterone acetate (DMPA); Device: Etonogestrel implant (Eng-Implant); Device: Levonorgestrel intrauterine device (Lng-IUD); Device: ParaGard® T 380A Intrauterine Copper Contraceptive
Sponsor: Lisa Haddad
Recruiting - Conditions: Substance-Related Disorders; Human Immunodeficiency Virus; Alcoholism
Interventions: Behavioral: Soccer League (SL); Behavioral: Soccer League/Vocational Training (SL-V)
Sponsors: University of California, Los Angeles; National Institute on Drug Abuse (NIDA)
Recruiting - Conditions: HIV Infections; Cardiovascular Diseases
Interventions: Drug: Pitavastatin; Drug: Placebo
Sponsors: National Institute of Allergy and Infectious Diseases (NIAID); National Heart, Lung, and Blood Institute (NHLBI); Kowa Pharmaceuticals America, Inc.; Gilead Sciences
Recruiting - Condition: HIV
Interventions: Behavioral: REC; Outreach if Failure; Behavioral: REC; SMS + Voucher if Failure; Behavioral: REC; Navigator if Failure; Behavioral: SMS; Outreach if Failure; Behavioral: SMS; Outreach if Failure; Stop SMS if Success; Behavioral: SMS; SMS+Voucher if Failure; Behavioral: SMS; SMS+Voucher if Failure; Stop SMS if Success; Behavioral: SMS; Navigator if Failure; Behavioral: SMS; Navigator if Failure; Stop SMS if Success; Behavioral: Voucher; Outreach if Failure; Behavioral: Voucher; Outreach if Failure; Stop Voucher if Success; Behavioral: Voucher; SMS+Voucher if Failure; Behavioral: Voucher; SMS+Voucher if Failure; Stop Voucher if Success; Behavioral: Voucher; Navigator if Failure; Behavioral: Voucher; Navigator if Failure; Stop Voucher if Success
Sponsors: University of California, San Francisco; University of California, Berkeley; Kenya Medical Research Institute; University of Washington
Recruiting - Condition: Acquired Immune Deficiency Syndrome Virus
Interventions: Drug: Dolutegravir; Drug: Darunavir/r
Sponsor: Juan A. Arnaiz
Recruiting - Conditions: Human Immunodeficiency Virus; HBV; Fibrosis, Liver; Cirrhosis, Liver; Hepatocellular Carcinoma; Hepatitis Delta Virus; Alcoholic Hepatitis
Intervention: Drug: Anti-HIV Agents
Sponsors: University of Alabama at Birmingham; John E. Fogarty International Center (FIC); National Institutes of Health (NIH)
Recruiting - Conditions: Human Immunodeficiency Virus 1 Positive; Stage I Adult Hodgkin Lymphoma; Stage I Adult Non-Hodgkin Lymphoma; Stage II Adult Hodgkin Lymphoma; Stage II Adult Non-Hodgkin Lymphoma; Stage III Adult Hodgkin Lymphoma; Stage III Adult Non-Hodgkin Lymphoma; Stage IV Adult Hodgkin Lymphoma; Stage IV Adult Non-Hodgkin Lymphoma
Interventions: Biological: C46/CCR5/P140K Lentiviral Vector-transduced Autologous HSPCs; Drug: Carmustine; Biological: Filgrastim; Other: Laboratory Biomarker Analysis; Drug: O6-Benzylguanine; Drug: Plerixafor
Sponsors: Fred Hutchinson Cancer Research Center; National Cancer Institute (NCI); National Heart, Lung, and Blood Institute (NHLBI)
Recruiting - Conditions: AIDS-Related Burkitt Lymphoma; AIDS-Related Diffuse Large B-cell Lymphoma; AIDS-Related Plasmablastic Lymphoma; AIDS-Related Primary Effusion Lymphoma; HIV Infection; AIDS Related Non-Hodgkin Lymphoma
Interventions: Drug: Prednisone; Biological: Rituximab; Drug: Etoposide; Drug: Doxorubicin Hydrochloride; Drug: Vincristine Sulfate; Drug: Cyclophosphamide; Biological: Filgrastim; Biological: Lentivirus Vector rHIV7-shI-TAR-CCR5RZ-transduced Hematopoietic Stem/Progenitor Cells
Sponsors: City of Hope Medical Center; National Cancer Institute (NCI)
Recruiting - Condition: Couples
Interventions: Behavioral: Couples HIV Testing and Counseling; Behavioral: at-home test kit
Sponsors: University of Michigan; University of Miami; University of Rochester
Recruiting - Condition: HIV Medication Adherence
Intervention: Behavioral: Adherence Readiness Program
Sponsors: RAND; University of California, Los Angeles; Long Beach Education and Research Consultants
Recruiting - Condition: HIV/AIDS
Interventions: Behavioral: Combined Contingency Management and Peer Navigation; Behavioral: Contingency Management; Behavioral: Peer Navigation
Sponsor: University of California, Los Angeles
Recruiting - Conditions: Binge Drinking; HIV
Interventions: Drug: Placebo; Drug: Naltrexone
Sponsors: University of California, San Francisco; San Francisco Department of Public Health; National Institutes of Health (NIH)
Recruiting - Conditions: HIV; Hepatitis C
Interventions: Behavioral: Motivational Interviewing; Behavioral: Brief Advice
Sponsor: Butler Hospital
Recruiting - Conditions: Depression; HIV
Intervention: Behavioral: Beating the Blues
Sponsor: Indiana University
Recruiting - Conditions: HIV; Medication Adherence
Intervention: Behavioral: SteadyRx
Sponsors: Johns Hopkins University; National Institute on Drug Abuse (NIDA); Western Michigan University
Recruiting - Condition: HIV-1
Interventions: Drug: F/TAF; Drug: 3rd ARV agent
Sponsor: Gilead Sciences
Recruiting - Condition: HIV-1 Infection
Intervention: Dietary Supplement: Zinc and SAMe
Sponsors: Emory University; National Institutes of Health (NIH); National Heart, Lung, and Blood Institute (NHLBI)
Recruiting - Condition: HIV Infections
Interventions: Biological: VRC01; Biological: VRC01LS
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting - Condition: HIV Infection
Intervention: Drug: DTG
Sponsor: PENTA Foundation
Recruiting - Conditions: HIV; Lipodystrophy
Intervention:
Sponsor: University of Colorado, Denver
Recruiting - Conditions: Sexually Transmitted Infections; Human Immunodeficiency Virus
Intervention: Behavioral: ESTIMA Intervention
Sponsor: University of California, San Diego
Recruiting - Conditions: Human Immunodeficiency Virus (HIV); Cardiovascular Disease (CVD)
Intervention: Drug: Rosuvastatin
Sponsors: Ottawa Heart Institute Research Corporation; Ontario HIV Treatment Network
Recruiting - Conditions: Chronic Obstructive Pulmonary Disease; HIV; Emphysema
Interventions: Procedure: blood draw; Procedure: questionnaires; Procedure: Lung function testing; Procedure: Six-Minute walk test; Radiation: Quantitative CT scans; Procedure: Nasal secretion and cell collection; Procedure: Echocardiogram
Sponsors: University of Pittsburgh; National Institutes of Health (NIH); National Heart, Lung, and Blood Institute (NHLBI)
Recruiting - Conditions: HIV; Infant Exposure to Efavirenz
Intervention:
Sponsors: University of North Carolina, Chapel Hill; Ministry of Health and Population, Malawi; University of North Carolina; Lighthouse Trust; Baylor College of Medicine; Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Recruiting - Condition: Patients Affected by the HIV
Intervention: Biological: OVIHD
Sponsor: Assistance Publique - Hôpitaux de Paris
Recruiting - Conditions: HIV; Stable ART
Intervention: Drug: ALT-803
Sponsor: University of Minnesota - Clinical and Translational Science Institute
Recruiting - Condition: HIV
Interventions: Behavioral: PATH For Triples; Behavioral: Treatment as Usual
Sponsor: University of Pennsylvania
Recruiting - Condition: HIV
Intervention:
Sponsors: University Hospital of Cologne; German Center for Infection Research; German Federal Ministry of Education and Research
Recruiting - Conditions: HIV; COPD; Pulmonary Disease; Aging
Interventions: Procedure: PFT; Procedure: lab work; Procedure: 6MWT; Other: questionnaires
Sponsors: University of Pittsburgh; National Heart, Lung, and Blood Institute (NHLBI)
Recruiting - Condition: HIV Infection
Intervention: Drug: Intensive ART regimen
Sponsors: International Maternal Pediatric Adolescent AIDS Clinical Trials Group; National Institute of Allergy and Infectious Diseases (NIAID); Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Recruiting - Conditions: HIV Infection; Fatigue
Intervention: Behavioral: Behavioral Activation Counseling
Sponsors: New York State Psychiatric Institute; Callen-Lorde Community Health Center
Recruiting - Condition: HIV Infection
Intervention:
Sponsors: International Maternal Pediatric Adolescent AIDS Clinical Trials Group; National Institute of Allergy and Infectious Diseases (NIAID); Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Recruiting - Conditions: Anal Cancer; High-grade Squamous Intraepithelial Lesion; HIV Infection; Human Papilloma Virus Infection
Interventions: Drug: imiquimod; Drug: fluorouracil; Device: infrared photocoagulation therapy; Device: thermal ablation therapy; Device: laser therapy; Other: clinical observation; Other: laboratory biomarker analysis
Sponsors: AIDS Malignancy Consortium; National Cancer Institute (NCI); The EMMES Corporation; University of Arkansas; University of California, San Francisco
Recruiting - Condition: HIV/AIDS
Intervention:
Sponsors: Harvard School of Public Health; Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD); National Institute on Drug Abuse (NIDA); National Institute of Allergy and Infectious Diseases (NIAID); NIH Office of AIDS Research (OAR); National Institute of Mental Health (NIMH); National Institute of Neurological Disorders and Stroke (NINDS); National Institute on Deafness and Other Communication Disorders (NIDCD); National Heart, Lung, and Blood Institute (NHLBI); National Institute of Dental and Craniofacial Research (NIDCR); National Institute on Alcohol Abuse and Alcoholism (NIAAA); Tulane University School of Medicine
Recruiting - Condition: HIV
Intervention: Other: exercise
Sponsor: VA Office of Research and Development
Recruiting - Conditions: Delinquency; HIV Risk; Substance Use; Trauma Exposure
Intervention: Behavioral: Integrated intervention for parents and adolescent girls
Sponsor: Oregon Research Institute
Recruiting - Condition: HIV Infection
Interventions: Drug: Aspirin 81 mg daily; Drug: Atorvastatin 40 mg daily
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting - Condition: Infection, Human Immunodeficiency Virus
Intervention: Drug: DTG 50 mg /ABC 600 mg /3TC 300 mg FDC tablets
Sponsors: ViiV Healthcare; GlaxoSmithKline
Recruiting - Conditions: Anal Intraepithelial Neoplasia; High-grade Squamous Intraepithelial Lesion; HIV Infection
Interventions: Drug: imiquimod; Drug: fluorouracil; Other: questionnaire administration; Other: laboratory biomarker analysis
Sponsors: AIDS Malignancy Consortium; National Cancer Institute (NCI); The EMMES Corporation; University of Arkansas
Recruiting - Conditions: HIV; Smoking; COPD
Intervention:
Sponsor: University of Colorado, Denver
Recruiting - Condition: HIV
Intervention:
Sponsor: Fundacion SEIMC-GESIDA
Recruiting - Conditions: HIV; COPD; Emphysema; Smoking
Intervention:
Sponsor: Weill Medical College of Cornell University
Recruiting - Conditions: Acquired Immune Deficiency Syndrome (AIDS); HIV Infections
Interventions: Drug: ATV; Drug: DRV; Drug: Cobicistat; Drug: BR
Sponsor: Gilead Sciences
Recruiting - Condition: HIV/AIDS
Intervention:
Sponsor: University of Colorado, Denver
Recruiting - Conditions: HIV; Pneumococcal Infections; Pneumococcal Vaccines
Interventions: Biological: PCV-13; Biological: PPSV-23
Sponsors: University of Colorado, Denver; National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting - Conditions: Hepatitis B; HIV
Intervention: Biological: Recombinant Hepatitis B Virus Vaccine
Sponsors: Universidad de Valparaiso; Roche Pharma AG; GlaxoSmithKline; Aclin Laboratories, Chile
Recruiting - Conditions: Healthy Volunteer; HIV Vaccine
Interventions: Biological: Ad4-mgag; Biological: Ad4-EnvC150
Sponsors: National Institute of Allergy and Infectious Diseases (NIAID); PaxVax, Inc.
Recruiting - Conditions: Acquired Immune Deficiency Syndrome Virus; Acquired Immunodeficiency Syndrome Virus; AIDS Virus; Human Immunodeficiency Virus; Human Immunodeficiency Viruses
Intervention:
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting - Conditions: HIV; COPD; Chronic Obstructive Pulmonary Disease; Smoking
Intervention:
Sponsor: Weill Medical College of Cornell University
Recruiting - Conditions: HIV; AIDS; Nicotine Dependence
Interventions: Drug: Bupropion; Behavioral: Brief Counseling; Behavioral: High-magnitude prize contingency management; Behavioral: Monitored support to quit smoking; Behavioral: No additional treatment; Behavioral: Prize contingency management for abstinence; Behavioral: Low intensity prize contingency management
Sponsors: Wayne State University; National Institute on Drug Abuse (NIDA)
Recruiting - Conditions: HIV Associated Neurocognitive Disorder; Human Immunodeficiency Virus
Intervention:
Sponsors: Emory University; National Institute of Mental Health (NIMH)
Recruiting - Condition: HIV Reservoirs
Intervention: Other: Blood sample and recto-colic biopsies
Sponsor: French National Institute for Health and Medical Research-French National Agency for Research on AIDS and Viral Hepatitis (Inserm-ANRS)
Recruiting - Conditions: HIV; Substance Related Disorders
Interventions: Drug: Buprenorphine/naloxone; Drug: Methadone Maintenance Therapy
Sponsors: Oregon Health and Science University; Hanoi Medical University; Minneapolis Medical Research Foundation
Recruiting - Conditions: Hepatitis B; Human Immunodeficiency Virus
Intervention:
Sponsor: Virginia Commonwealth University
Recruiting - Condition: HIV
Intervention:
Sponsor: Gilead Sciences
Recruiting - Condition: HIV
Intervention: Drug: Switch to Maraviroc + Raltegravir or Dolutegravir
Sponsor: University of Maryland
Recruiting - Condition: HIV
Intervention:
Sponsor: Gilead Sciences
Recruiting - Conditions: Opiate Dependence; Human Immunodeficiency Virus
Interventions: Drug: injectable naltrexone; Drug: placebo comparator
Sponsors: University of Pennsylvania; National Institute on Drug Abuse (NIDA)
Recruiting - Conditions: Bacterial Infection; HIV
Interventions: Behavioral: SKIN Intervention; Other: Treatment as Usual
Sponsor: Butler Hospital
Recruiting - Conditions: Acquired Immunodeficiency; Neurocognitive Disorders
Intervention:
Sponsor: National Institute of Neurological Disorders and Stroke (NINDS)
Recruiting - Conditions: Acquired Immune Deficiency Syndrome Virus; Hepatitis C; Drug Abuse
Intervention: Other: MI-based HIV Risk Reduction
Sponsors: Michele Staton; National Institute on Drug Abuse (NIDA)
Recruiting - Condition: HIV
Intervention: Drug: Enfuvirtide
Sponsor: Sidney Kimmel Comprehensive Cancer Center
Recruiting - Condition: HIV
Intervention:
Sponsor: Sichuan Academy of Medical Sciences
Recruiting - Condition: HIV Infections
Intervention: Drug: Raltegravir
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting - Condition: HIV
Intervention: Drug: Atripla or Stribild
Sponsors: Fred Hutchinson Cancer Research Center; Asociación Civil Impacta Salud y Educación, Peru; NGO Via Libre; Epicentro, Barranco District, Peru
Recruiting - Conditions: Advanced Malignant Solid Neoplasm; HIV Infection; Metastatic Malignant Solid Neoplasm; Recurrent Malignant Solid Neoplasm; Unresectable Solid Neoplasm
Interventions: Drug: Cabozantinib S-malate; Other: Laboratory Biomarker Analysis; Other: Pharmacological Study
Sponsor: National Cancer Institute (NCI)
Recruiting - Condition: HIV Infections
Intervention: Drug: Raltegravir
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting - Condition: HIV
Interventions: Drug: antiretroviral therapy; Behavioral: cell phone reminders; Behavioral: contingency management for adherence
Sponsors: UConn Health; Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Recruiting - Conditions: AIDS-Related Hodgkin Lymphoma; Ann Arbor Stage II Hodgkin Lymphoma; Ann Arbor Stage IIA Hodgkin Lymphoma; Ann Arbor Stage IIB Hodgkin Lymphoma; Ann Arbor Stage III Hodgkin Lymphoma; Ann Arbor Stage IIIA Hodgkin Lymphoma; Ann Arbor Stage IIIB Hodgkin Lymphoma; Ann Arbor Stage IV Hodgkin Lymphoma; Ann Arbor Stage IVA Hodgkin Lymphoma; Ann Arbor Stage IVB Hodgkin Lymphoma; Classical Hodgkin Lymphoma; HIV Infection
Interventions: Drug: Brentuximab Vedotin; Drug: Dacarbazine; Drug: Doxorubicin Hydrochloride; Other: Laboratory Biomarker Analysis; Other: Pharmacological Study; Drug: Vinblastine
Sponsor: National Cancer Institute (NCI)
Recruiting - Conditions: HIV Infections; Tuberculosis
Intervention: Drug: Raltegravir
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting - Conditions: Risk Behavior; Medication Adherence; HIV
Interventions: Behavioral: 3H+ (Holistic Health for HIV); Behavioral: HHRP+ (Holistic Health Recovery Program)
Sponsors: University of Connecticut; National Institute on Drug Abuse (NIDA); Yale University; APT Foundation, Inc.
Recruiting - Condition: HIV
Intervention:
Sponsor: Kaohsiung Medical University Chung-Ho Memorial Hospital
Recruiting - Conditions: AIDS; Tuberculosis
Intervention: Drug: Lopinavir/ritonavir and ritonavir
Sponsors: University of Miami; Oswaldo Cruz Foundation
Recruiting - Conditions: HIV; Childhood; Natural History; Cardiac; ART
Intervention:
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting - Conditions: Anal Cancer; Cervical Cancer; Lung Cancer; Lymphoma
Interventions: Genetic: DNA analysis; Genetic: RNA analysis; Genetic: gene expression analysis; Genetic: polymorphism analysis; Other: biologic sample preservation procedure; Other: flow cytometry; Other: laboratory biomarker analysis; Other: medical chart review
Sponsors: AIDS Malignancy Consortium; National Cancer Institute (NCI); The EMMES Corporation; AIDS and Cancer Specimen Resource; University of Arkansas
Recruiting - Condition: HIV-1 Infection
Interventions: Drug: Coformulated EFV/FTC/TDF; Drug: Etoposide; Drug: Bleomycin and Vincristine (BV); Drug: Paclitaxel (PTX)
Sponsors: AIDS Clinical Trials Group; National Institute of Allergy and Infectious Diseases (NIAID); National Cancer Institute (NCI); National Institute of Dental and Craniofacial Research (NIDCR)
Recruiting - Condition: HIV-infection
Intervention: Procedure: Colon biopsy, lymph node biopsy, lumbar puncture
Sponsors: South East Asia Research Collaboration with Hawaii; Armed Forces Research Institute of Medical Sciences, Thailand; Thai Red Cross AIDS Research Centre
Recruiting - Conditions: Hepatitis; HIV; Liver Cancer
Intervention:
Sponsors: National Institutes of Health Clinical Center (CC); Washington D.C. Veterans Affairs Medical Center
Recruiting - Condition: HIV Infections
Interventions: Drug: Dolutegravir (DTG) film-coated tablets; Drug: DTG granules for suspension; Drug: DTG dispersible tablets
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting - Condition: Antiretroviral Toxicity
Intervention:
Sponsors: Harvard School of Public Health; Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD); National Institute on Drug Abuse (NIDA); National Institute of Allergy and Infectious Diseases (NIAID); National Institute of Mental Health (NIMH); National Heart, Lung, and Blood Institute (NHLBI); National Institute on Deafness and Other Communication Disorders (NIDCD); National Institute on Alcohol Abuse and Alcoholism (NIAAA); National Institute of Neurological Disorders and Stroke (NINDS); Tulane University School of Medicine; National Institute of Dental and Craniofacial Research (NIDCR); NIH Office of AIDS Research (OAR)
Recruiting - Conditions: HIV; AIDS
Intervention:
Sponsors: George Washington University; National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting - Condition: Infection, Human Immunodeficiency Virus
Intervention: Drug: Any Antiretroviral Therapy
Sponsors: ViiV Healthcare; GlaxoSmithKline
Recruiting - Condition: HIV Infections
Intervention:
Sponsors: Radboud University; PENTA Foundation; Merck Sharp & Dohme Corp.; Bristol-Myers Squibb; Janssen Pharmaceutica; ViiV Healthcare
Recruiting - Condition: Acute HIV Infection
Interventions: Drug: HAART; Drug: Mega-HAART
Sponsors: South East Asia Research Collaboration with Hawaii; Thai Red Cross AIDS Research Centre; Pfizer; Gilead Sciences; Merck Sharp & Dohme Corp.; ViiV Healthcare
Recruiting - Condition: Human Immuno Deficiency (HIV) Infection
Interventions: Drug: Rilpivirine; Drug: Zidovudine; Drug: Abacavir; Drug: Tenofovir disoproxil fumarate; Drug: Lamivudine; Drug: Emtricitabine
Sponsor: Janssen Sciences Ireland UC
Recruiting - Condition: Acute HIV Infection
Intervention:
Sponsors: South East Asia Research Collaboration with Hawaii; Armed Forces Research Institute of Medical Sciences, Thailand; Thai Red Cross AIDS Research Centre
Recruiting - Conditions: HIV Infections; AIDS; Opportunistic Infections
Intervention:
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting - Condition: HIV
Intervention:
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting - Condition: HIV Infections
Interventions: Drug: Dolutegravir; Drug: Elvitegravir, Cobicistat, Emtricitabine, and Tenofovir Alafenamid Fumarate; Drug: Raltegravir; Drug: Darunavir; Drug: Ritonavir; Drug: Rilpivirine; Drug: Lamivudine; Drug: tenofovir; Drug: Emtricitabine; Drug: Abacavir
Sponsor: University of Zurich
Recruiting - Condition: HIV Infections
Intervention:
Sponsors: Microbicide Trials Network; National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting - Conditions: HIV Infections; Hepatitis B
Intervention:
Sponsors: INC Research; AbbVie; Apotex Inc.; Aurobindo Pharma; Boehringer Ingelheim; Bristol-Myers Squibb; Cipla Ltd.; Hoffmann-La Roche; Gilead Sciences; Hetero Labs Ltd.; Janssen Scientific Affairs; Lupin Pharmaceuticals, Inc.; Merck Sharp & Dohme Corp.; Mylan Laboratories; Novartis Pharmaceuticals; Pfizer; Prinston Pharmaceutical Inc.; Ranbaxy Inc., a SunPharma Co.; Sandoz; Sciegen Pharmaceuticals Inc.; Sigmapharm Laboratories; Silarx Pharmaceuticals Inc; Strides Shasun Ltd.; Teva Pharmaceuticals USA; ViiV Healthcare; Alvogen Korea; Amneal Pharmaceuticals, LLC; West-Ward Pharmaceutical; Dr. Reddy's Laboratories UK Ltd.; Zentiva Group
Recruiting - Conditions: Liver Disease; Steatohepatitis; HIV
Intervention:
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting - Condition: HIV Infections
Intervention: Other: blood draw
Sponsor: Rockefeller University
Recruiting - Conditions: Blood Component Removal; Human Immunodeficiency Virus
Intervention:
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting - Condition: HIV Infections
Interventions: Drug: atazanavir/cobicistat; Drug: darunavir/ritonavir; Drug: darunavir/cobicistat; Drug: etravirine; Drug: elvitegravir/cobicistat; Drug: dolutegravir; Drug: tenofovir alafenamide fumarate (TAF); Drug: TAF/cobicistat; Drug: TAF/ritonavir; Drug: efavirenz; Drug: lopinavir/ritonavir; Drug: nevirapine; Drug: rifampicin; Drug: ethambutol; Drug: isoniazid; Drug: pyrazinamide; Drug: kanamycin; Drug: amikacin; Drug: capreomycin; Drug: moxifloxacin; Drug: levofloxacin; Drug: ofloxacin; Drug: ethionamide/prothionamide; Drug: terizidone/cycloserine; Drug: para-aminosalicylic acid (PAS); Drug: high dose isoniazid (INH); Drug: bedaquiline; Drug: clofazamine; Drug: delamanid; Drug: linezolid; Drug: pretomanid; Drug: atazanavir/ritonavir/tenofovir; Drug: ethinyl estradiol oral contraceptive; Drug: etonogestrel implant
Sponsors: National Institute of Allergy and Infectious Diseases (NIAID); Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Recruiting - Condition: HIV
Intervention:
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting - Condition: HIV Infections
Intervention:
Sponsors: AIDS Clinical Trials Group; National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting - Condition: Human Immunodeficiency Virus
Intervention:
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting - Conditions: HIV; Kaposi's Sarcoma; Lymphomas; Multicentric Castleman's Disease; Primary Effusion Lymphoma
Intervention:
Sponsor: National Cancer Institute (NCI)
Recruiting - Conditions: Lymphoma, AIDS-related; Lymphoma, Large B-Cell, Diffuse
Interventions: Biological: Rituximab; Biological: filgrastim; Drug: EPOCH
Sponsor: National Cancer Institute (NCI)
Recruiting - Condition: HIV Infection
Intervention:
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting - Condition: HIV Infection
Intervention:
Sponsors: National Institute of Allergy and Infectious Diseases (NIAID); Washington Hospital Center
Recruiting - Conditions: HIV Infection; Immunologic Deficiency Syndrome
Intervention:
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting - Conditions: HIV; Healthy Volunteers
Intervention:
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting - Conditions: AIDS Associated Nephropathy; Focal Glomerulosclerosis; HIV Infections
Intervention:
Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Recruiting
Clinical Trial Locations